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Abstract 
 
Background: To help document and improve early enrollment and retention in HIV care in 2011, the 
Swaziland Ministry of Health implemented a new set of standard operating procedures on linkage and 
retention (National SOP).  The National SOP was implemented as part of two programs: the Soka 
Uncobe male circumcision campaign (SOKA) in 2011 and 2012, during which HIV testing was facility-
based, and the Swaziland HIV Incidence Measurement Survey (SHIMS) in 2011, during which HIV testing 
was home-based.  The purpose of this study was to evaluate (1) compliance with the National SOP, and 
(2) early enrollment and retention in HIV care among newly HIV diagnosed SOKA and SHIMS clients.   
Methods: The study included two components. Component I was a retrospective cohort analysis of 
1,105 newly HIV-diagnosed SOKA and SHIMS clients.  Routinely collected program data on this 
retrospective cohort were abstracted from multiple sources including HIV testing and counseling forms 
(referral forms), and records maintained at facilities where clients were referred and elected to enroll in 
HIV care.  Component II was a telephone survey of clients who were not initially verified to have 
enrolled in care at facilities to which they were referred.  The brief survey ascertained if and where the 
client enrolled in care, and for those clients who did not enroll, reasons for not enrolling in care.  For 
clients who reported enrolling in care, study personnel visited facilities to verify enrollment and 
abstracted data from client records in accordance with Component I procedures.  
Results: The 1,105 clients (494 SHIMS females, 294 SHIMS males, 317 SOKA males), diagnosed with HIV 
at a median (Q1-Q3) age of 29 (24-35) years, were referred to 69 HIV care facilities throughout 
Swaziland (18 in Hhohho, 16 Lubombo, 17 Manzini, 18 Shiselweni).  Most clients were referred to 
government (71.4%) facilities categorized as clinics (47.4%) or hospitals (34.4%).  At referral facilities, 
referral forms were located for only half (46.8%) of the clients; few (9.6%) were recorded in the 
appointment register and called either before (0.3%) or after (4.9%) their appointment.  Of 267 clients 
interviewed, few (9.0%) reported receiving a phone call from the referral facility.  After adjusting for 
non-response, of 1,105 clients, an estimated 464 (41.9%) enrolled in HIV care overall, and 155 (14.0%), 
192 (17.3%), 269 (24.3%), 342 (30.9%), and 409 (37.0%) within 3, 6, 12, 18, and 24 months of diagnosis, 
respectively.  Of interviewed clients, the most common reasons reported for not enrolling in care 
included perceived good health, and care that is inconvenient or costly.  Of 300 clients verified to have 
enrolled in HIV care, at enrollment, 66.0% were ART eligible based on national guidelines (CD4 < 350 
cells/µl or WHO stage III or IV).  Of ART-eligible clients at enrollment, 94.4% were initiated on ART and 
86.5% were retained on ART two years after initiation. Of the few clients who enrolled in pre-ART care, 
54.8% and 35.1% were retained in pre-ART care one and two years after enrollment, respectively. 
Conclusion:  Of over one thousand clients newly HIV diagnosed in two settings in Swaziland in 2011 and 
2012, very few received linkage services in accordance with the National SOP, and less than 40% were 
estimated to have enrolled in HIV care within two year of their diagnosis.  Of the few clients found to 
enroll in pre-ART care, most were not retained in care after 12 months of enrollment.  The findings from 
this retrospective study (RetroLink) are a call to action to assess and improve linkage services, and early 
enrollment and retention in HIV care in Swaziland.    
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Key Definitions 
 
1. Newly HIV-diagnosed.  As recorded on the HTC form, newly HIV-diagnosed clients were defined as 
(1) having tested HIV-positive at the SHIMS or SOKA encounter, and (2) either never previously 
testing for HIV or last testing HIV-negative.       
2. Data-abstraction match.  A data-abstraction match was defined as a clinical record (e.g., chronic 
care file, electronic medical record) that matched on the HTC form the first or last name of the 
client, client gender, and at least one of the following variables: date of birth, physical address, 
telephone contact number, next of kin or treatment supporter, or telephone number of next of kin.   
3. Partial match.  A partial match was defined as a clinical record that matched information on the HTC 
form on one variable alone.   All partial matches were evaluated and resolved by team leaders as 
either a match or non-match.   Only data from those records that met the above matching criteria 
could be abstracted onto data abstraction forms. 
4. Referral facility.  Referral facilities are locations where clients were referred for HIV care at HIV 
diagnosis.  As part of the eligibility criteria, the referral facility name had to be legibly recorded on all 
HTC forms included in this study.   
5. Enrollment facility.  Enrollment facilities are locations where >1 clients were verified as having 
enrolled in HIV care.   
6. Non-enrollment facility.  Non-enrollment facilities are locations where clients were either referred 
for HIV care or where clients reported having enrolled in care, but where no clients were verified as 
having enrolled in care. 
7. Enrollment appointment.  The enrollment appointment is the date of appointment clients were 
given to enroll in HV care.  This date, typically within two-weeks of HIV diagnosis, was recorded on 
the HTC form with the name of the referral facility.  In accordance with the national linkage SOP, the 
enrollment appointment was to be used by referral facility staff as the date to record clients in the 
clinic appointment register.  
8. Enrollment in HIV care.  Enrollment in care is defined as documentation of either (1) having been 
clinically staged at an HIV care facility using the World Health Organization (WHO) HIV staging 
criteria, or (2) having received services at an HIV care facility at least once after the date a CD4 test 
was conducted.  Thus, for the purposes of this report, enrollment in care presumes clients were 
informed of their ART-eligibility status based on WHO stage or CD4-count result.  
9. Date of enrollment in HIV care.  Date of enrollment in care is defined as the earliest date on which 
either enrollment criterion was met.   
10. Baseline clinical characteristics.  Baseline clinical characteristics are defined as WHO clinical staging 
and CD4-cell count that were abstracted from the pre-ART enrollment visit page of the chronic care 
file, or the earliest date identified for these clinical assessments. Because psychosocial assessments 
(e.g., disclosure to partners and family members) are supposed to be conducted at the time of or 
soon after enrollment, findings from these assessments are also included as part of baseline 
characteristics.    
11. Pre-ART Care.  HIV care, including clinical and psychosocial assessment and support services 
provided to patients who are not eligible for ART in accordance with the Swaziland national HIV care 
and treatment guidelines.    
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12. ART eligibility.  ART eligibility is defined as having a CD4 <350 cells/µl (regardless of clinical stage) or 
a WHO clinical stage of III or IV (regardless of CD4 count). 
13. Retained in pre-ART care.   For pre-ART clients, retention in care was defined as having a documented 
visit at the facility within 151 days from the date of data abstraction.  In accordance with national 
treatment guidelines, the recommended interval of time between pre-ART-care visits is 120 days.21 
14. Retained in ART care.  For ART clients, retention in ART care was defined as having a documented visit 
at the facility within 90 days from the date of data abstraction.  In accordance with national treatment 
guidelines, the recommended interval of time between ART-care visits is 30 days.22  
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Introduction 
 
Background 
Limited information is available on the magnitude and correlates of early enrollment and retention in 
HIV care among HIV diagnosed persons in resource-limited countries.  Studies from South Africa suggest 
that one- to two-thirds of newly HIV-diagnosed persons do not enroll early in HIV care.1,2 In a study from 
Mozambique where 7,005 patients were diagnosed with HIV during a 12-month period, only 3,956 
(57%) enrolled in care within 30 days of their diagnosis.3  Further, a recent meta-analysis of studies 
conducted in Africa suggests that many newly HIV-diagnosed clients either do not enroll or drop out of 
care within 6 months of diagnosis, and as a result, many patients initiate antiretroviral therapy (ART) 
late in the course of their HIV disease.4  Late ART initiation is associated with increased risk of HIV 
morbidity and mortality, and transmission to uninfected sex partners.5-9 Thus, to help reduce HIV 
morbidity and mortality, additional information is needed on the magnitude of early enrollment and 
retention in HIV care among newly HIV diagnosed persons, and whether services implemented to 
promote enrollment in care are effective.  This need is particularly acute for countries with high HIV 
morbidity and for groups known to be at high risk for delayed enrollment in or defaulting from HIV care.  
 
Of all countries, Swaziland has the highest estimated HIV prevalence, with an estimated 32% of the adult 
population 18-49 years of age infected with HIV.10 A recent evaluation of the Swaziland ART program for 
2004-2010 found that more than 50% of patients initiate ART late in the course of their disease with a 
median CD4 <100 cells/µl.11 While many factors contribute to late initiation of ART, delay in enrollment in 
care following HIV diagnosis is thought to be particularly important.12-14 To help document and improve 
early enrollment and retention in HIV care, the Swaziland Ministry of Health implemented in 2011 a new 
set of linkage and retention standard operating procedures (National SOP).15  The National SOP was 
implemented in multiple HIV-care facilities, and for clients HIV tested at Soka Uncobe male circumcision 
sites (SOKA) in 2011 and 2012, and at homes during the Swaziland HIV Incidence Measurement Survey 
(SHIMS) in 2011.  Providing linkage services and documenting enrollment in care of SOKA and SHIMS 
clients are particularly important because young men and persons diagnosed at home are at high risk for 
delayed enrollment and retention in HIV care.16-20  
 
This retrospective study (Project RetroLink) was implemented to meet the above needs by evaluating 
compliance with the National SOP, and determining the magnitude and correlates of early enrollment 
and retention in HIV care among newly HIV diagnosed persons.  The study population of RetroLink 
included both SOKA and SHIMS clients who were newly HIV diagnosed because these were the first two 
HTC populations among whom the National SOP was implemented.   
 
Swaziland Linkage and Retention SOP 
Although the National SOP was implemented with standard methods to document and track linkage to 
care, different linkage services were available for the two HTC populations.  The common tracking and 
different linkage procedures are described below. 
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Client Tracking  
Procedures for tracking clients from HIV diagnosis to enrollment in HIV care were based on the use of 
the same HTC form that was completed on all clients who were HIV tested in the two settings.15 
Produced in triplicate (white, pink, and yellow copies), the HTC form was used to not only document 
program indicators at the client level, but also to refer those clients for follow-up medical and social 
services (Appendix A).  Facilities to which clients were referred (referral facilities) were recorded at the 
bottom of the form, including the date of appointment.  If obtained, consent for follow-up contact was 
recorded on the HTC form, as well as the telephone number of the client and the name and telephone 
number of the next of kin (Appendix A).  In accordance with the National SOP, clients who tested HIV-
positive were informed that the purpose of follow-up calls is for staff at the referral facility to remind 
clients of their upcoming appointment and to encourage them to enroll in HIV care.15  Once complete, 
the white copy of the form was given to the client to present to facility staff during registration; the pink 
copy was sent to the referral facility via the national sample transport system courier; and the yellow 
copy remained with the HTC provider.15  
 
Linkage Services 
Upon receipt of the pink copy of the HTC form, referral facility staff were expected to record the client’s 
name in the appointment register on the date of appointment and store the pink copy in an “Expected 
Patients” binder.15 Facility staff were expected to review the appointment register on a daily basis.  One 
day before the enrollment appointment, for those clients who provided consent and a telephone 
number, staff were expected to either send an SMS text reminder or to call and remind clients of their 
appointment the following day, and to clarify and resolve any barriers for enrolling in care.15 Clients who 
missed their appointment were to be called again after 3 days to assess and resolve barriers to care and 
to schedule another appointment.  Facility staff were expected to review the appointment register daily 
for clients who missed their appointments and document all calls in the call register (sometimes the pink 
copy of the HTC form was used to document call attempts).15  Clients who consented for follow-up 
contact who could not be reached by phone could also be visited at home through standard defaulter 
tracing procedures.15   For clients who visited the facility, the white copy of the HTC form (if presented) 
was attached to the pink copy and both were to be placed in an “Arrived Patients” binder.15   
 
SOKA-specific Linkage Services 
At Population Services International (PSI) supported male circumcision clinics (SOKA sites), after 
standard post-test counseling, clients who tested HIV positive were offered the opportunity to speak 
with an HIV-positive expert-client (EC) counselor.  EC counselors explained the nature and value of HIV 
care, used a standard form (HIV care readiness assessment form) to identify and resolve barriers to care, 
and in some settings, escorted and helped clients register at co-located HIV care facilities (Appendix B).  
PSI EC counselors did not have any follow-up responsibilities with clients after the single post-test 
counseling session (although some counselors were known to contact some clients on their own).  EC 
counselors were not available for SHIMS clients who were tested at their home.   
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Primary Study Objectives 
The primary study objectives of RetroLink included the following:  
 
Compliance with the National SOP  
1. Linkage services 
a. The proportion of referred, newly HIV diagnosed clients for whom a pink referral copy was 
located at the referral facility. 
b. The proportion of clients for whom at least one telephone contact attempt was 
documented to remind the client of his/her upcoming appointment to enroll in care. 
c. The proportion of clients who were successfully contacted by phone to remind them of 
their upcoming appointment. 
2. Appointment defaulter tracing 
a. The proportion of referred, newly HIV-diagnosed clients who did not link to care within 14 
days of their appointment who consented to and provided telephone contact information.  
b. The proportion of clients in 2(a) for whom at least one telephone contact attempt was 
documented.  
c. The proportion of clients in 2(b) who were successfully contacted, as documented on the 
pink form or telephone log.  
Enrollment & Retention in HIV Care 
3. Enrollment in Care 
a. The proportion of referred clients who enrolled in care for whom a white HTC form was 
located at the facility.  
b. The proportion of referred clients who enrolled in care at the referral facility within 3 
months of their diagnosis (early enrollment in care), and the median (Q1-Q3) interval of 
days from diagnosis to enrollment in care. 
c. The proportion of clients who were not initially verified as having enrolled in care at the 
referral facility who were successfully contacted by phone by study personnel. 
d. The proportion of clients in 3(c) who reported and were verified to have enrolled in HIV 
care. 
e. The distribution of reasons for enrolling in care at non-referral facilities, and reasons for 
not enrolling in care at any facility.  
f. The proportion of clients who enrolled in care and who at baseline were ART-eligible and 
the proportion who had AIDS or CD4 <200 cells/µl. 
4. Early retention in care 
a. The proportion of referred clients who were ART-eligible at baseline who were 
subsequently initiated on ART. 
b. The median (Q1-Q3) interval in days from HIV diagnosis to ART initiation among referred 
clients ART-eligible at baseline. 
c. The proportion of enrolled clients in pre-ART and ART care who were retained in care 6 and 
12 months after enrollment or ART initiation. 
d. The median (Q1-Q3) number of follow-up facility visits at which clients were screened for 
tuberculosis and prescribed cotrimoxazole.   
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Methods 
 
Study Populations 
The two study populations of RetroLink were eligible clients newly HIV-diagnosed through (1) home-
based HTC conducted as part of SHIMS from February 1, 2011 through June 30, 2011, and (2) provider-
initiated HTC conducted at 13 male circumcision sites as part of Soka Uncobe from March 1, 2011 
through March 31, 2012.   
 
Eligibility 
Eligibility for RetroLink was based on a comprehensive review of archived HTC forms used during SHIMS 
and Soka Uncobe.  As the implementing partner of SHIMS, ICAP archived HTC forms at the country office 
in Mbabane.  HTC forms used during Soka Uncobe were archived at care and treatment facilities located 
throughout Swaziland.  To be considered eligible, all HTC forms had to have complete and legible 
information for each of the following variables: client first and last name, date of birth, test date, 
gender, ever previously tested for HIV, most recent HIV test result, attendance at an HIV care facility in 
the last 3 months, final HIV test result, and name of referral facility (Appendix A).  Additionally, only 
clients on whom HTC forms indicated that they had tested HIV-positive, and (1) had never previously 
tested for HIV or (2) had last tested HIV-negative were defined as newly HIV diagnosed and considered 
eligible for the study, provided the required referral threshold was met (see Sample Restriction below).    
 
Study Design and Client Selection 
Two design components were included in this evaluation.  Component I was a retrospective cohort 
study of eligible SHIMS and SOKA clients.  Component II was a brief cross-sectional telephone survey of 
Component I clients on whom enrollment in HIV care was not initially verified at the referral facility. 
 
Component I Selection 
To select clients for Component I, study personnel reviewed all located copies of SHIMS HTC forms 
archived at the ICAP country office, and all located copies of SOKA HTC forms archived at 13 of 31 SOKA 
sites (Appendix C).  Teams of approximately 4 persons reviewed all archived HTC forms and separated all 
forms of clients who tested HIV-positive.  Two staff, one of whom was fluent in siSwati (the official 
language in Swaziland), then independently reviewed each HIV-positive HTC form against the above set 
of eligibility criteria.   Having one staff member fluent in siSwati was needed to ensure client names 
were accurately recorded.  Both staff had to agree that all the eligibility criteria were met, and only 
those HTC forms that met all eligibility criteria were chosen.  For SOKA clients, the 13 sites were selected 
because they provided 89.1% of all clients who tested HIV-positive during the Soka Uncobe campaign 
(insufficient resources were available to review all archived HTC forms at all 31 facilities).21 An 
incomplete but unknown percentage of HTC forms of all SHIMS participants were archived at the ICAP 
country office (personal communication, Jessica Justman, SHIMS Principal Investigator, ICAP-Columbia).   
 
SOKA Sample Restriction 
After eligible study forms were selected, only those forms of clients referred to HIV care facilities with 
>3 referrals for SOKA clients were included in this evaluation (referral threshold).  This referral threshold 
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was imposed because insufficient resources were available to visit all facilities to which SOKA clients 
were referred.   A referral threshold was not imposed on selecting eligible SHIMS forms because the 
protocol sampling plan called for a 1:1 ratio of selected male clients from SOKA and SHIMS (to optimize 
power to detect outcome differences in these two groups).  For the range of expected enrollment-in-
care rates among MC clients (55%-75%), a sample size of 520 males (260 in each group) was planned to 
provide >80% power to detect absolute differences of enrollment-in-care rates that were 13% or lower 
among SHIMS clients compared with MC clients.  The original sampling plan also called for including 473 
SHIMS female clients to match the same selection probability for sampling SHIMS male clients.  To meet 
the target sample sizes and achieve the 1:1 ratio of selected male clients from SOKA and SHIMS, all 
located HTC forms of eligible SHIMS males had to be selected for the study.  Because all located HTC 
forms of eligible males were selected, all located HTC forms of eligible SHIMS females were also selected 
for the study.  Excluding clients who were initially thought as eligible but who were determined to be 
previously diagnosed based on examination of clinical records, the final sample size for each study-
gender group was slightly more than the original targets (Figure 1).   
 
Component II Selection 
Component II was restricted to the subset of Component I clients who (1) were not initially verified to 
have enrolled in HIV care at the referral facility, and (2) consented to be contacted and provided a 
telephone number on their HTC form. 
 
Study Measures 
Data Collection Forms 
The following forms were used to collect data for this study: (1) data abstraction form (DAF), (2) clinic 
characteristics form (CCF), (3) data source form (DSF), and (4) the defaulter tracing form (DTF).  Study 
measures included on each of these forms are summarized below.  Refer to the list of definitions for key 
measures (page 6).  
 
Data abstraction form. The DAF was used to measure implementation of national linkage procedures 
and enrollment and retention in HIV care (Appendix D).  The DAF included measures on demographic 
characteristics (e.g., age and sex); HIV diagnosis and referral (e.g., date of HIV diagnosis and name of 
referral facility); expected National SOP management procedures (e.g., storage of pink and white copies 
of HTC forms at referral facilities, documentation of enrollment appointments); expected national 
linkage procedures (e.g., telephone reminders before appointments and calls after missed 
appointments); and among clients who enrolled in care, clinical services received and client 
characteristics through the date of abstraction (e.g., baseline and follow-up CD4 testing and WHO 
staging, ART initiation, cotrimoxazole prescription, screening for TB, etc.). 
 
Clinic characteristics form.  The CCF was used to measure facility characteristics that might be associated 
with enrollment and retention in care (Appendix E).  These characteristics include the type, class, and 
location of facilities (e.g., government, private, hospital, clinic, rural, urban); clinic services, operations, 
and staffing (e.g., days open, number and types of HIV-care providers, ART initiation or refill services, 
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etc.); and capacity to call clients in accordance with national linkage procedures (e.g., availability of 
telephone, monthly airtime credit, responsible personnel, etc.). 
 
Data source form.  The DSF was used at each facility to measure the availability of data sources that 
study personnel used to locate, match, and abstract data on eligible clients (Appendix F).  Data sources 
inventoried at each facility included expected and arrived patient binders; electronic medical records 
(EMRs); chronic care files; and appointment, call, pre-ART, ART, and laboratory registers.  For 
appointment, pre-ART, and ART registers, the total months that registers were available were recorded 
for calendar years 2011, 2012, and 2013.  Register availability was measured in months because even 
though registers were available for a calendar year (e.g., 2011), parts of the register could be missing 
(e.g., sections that were torn from the register).     
 
A summary index of data-source availability, ranging from 1 (optimal availability) to 4 (inadequate 
availability) was calculated based on the availability of an electronic medical record system; EC 
counselors (who were used to identify and locate files of clients); and appointment, pre-ART, and ART 
registers for calendar years 2011, 2012, and 2013.  Category 1 was defined as EMR, EC, and 108 register 
months available for each of the three registers.  Category 4 was defined as not having any of these data 
sources available, including not having any register months available for years 2011, 2012, and 2013 for 
each of the three registers (see Table 10 footnote for complete definition). 
 
Defaulter Tracing Form.  The DTF was used for all Component II eligible clients and served as the 
standardized questionnaire administered to those clients who were contacted by telephone and 
consented to be interviewed (Appendix G).  The DTF measured Component II processes (e.g., telephone 
contact attempts; success at contacting and consenting clients); information about their post-test 
counseling session (e.g., if the client remembered being referred to HIV care and the name of the 
referral facility, if applicable); enrollment and retention in HIV care (e.g., name of facilities where the 
client enrolled and is currently receiving HIV care, dates of enrollment and last visit); and reasons for 
enrolling at a facility different from the referral facility or not enrolling in care at all (e.g., perceived good 
health, costs and quality of HIV care, accessibility, etc.).   
 
Facility Data Sources 
Component I 
For Component I, the following data sources were used to meet the two broad objectives of the 
evaluation.   
 
Study Objectives Data Sources 
  
1. Evaluation of Compliance with 
National Linkage and Retention 
Procedures 
Expected Patients Binder (Pink HTC Forms) 
Arrived Patients Binder (White HTC Forms) 
Appointment Register for 2011-2014 
Call Registers for 2011-2014 
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2. Evaluation of Enrollment and 
Retention Outcomes 
Chronic Care Files 
Electronic Medical Record 
 Pre-ART Registers for 2011-2014 
 ART Registers for 2011-2014 
 Laboratory Registers for 2011-2014 
 
Data Collection 
Preparing for Data Abstraction.   
One DAF was created for each of the SHIMS and SOKA clients selected for the study prior to data 
collection.  Client identifiers (e.g., first and last name, date of birth, telephone number, etc.) used for 
matching client medical records were transcribed onto DAFs from corresponding fields from selected 
HTC forms.  DAFs were then grouped according to referral facilities and dispatched with a data-
abstraction team to that facility.   
 
In advance of the team’s arrival, each facility was phoned or visited by the study facility coordinator.  
The study facility coordinator recorded the name and phone number of the facility’s point of contact, 
and the availability, location, and missing dates of data sources. This information was provided to the 
field supervisor of the assigned team to help plan data abstraction activities.  Whenever possible, an 
appointment date and time for the team’s visit was established in advance to ensure the availability of 
relevant facility personnel and to improve access to data sources. 
 
During data-abstraction visits, field supervisors located the facility’s primary point of contact or designee 
to introduce the team, explained the purpose and methods of the study, and provided a letter of 
authorization from the Swaziland MOH.  Clinic staff and team supervisors then identified a secure 
workspace and assembled or located data sources required for identifying enrolled clients. 
 
Evaluation of National Linkage and Retention Procedures 
To evaluate national linkage procedures, the abstraction teams located and searched all HTC forms 
within the expected and arrived patients binders or envelopes.  In accordance with standard 
procedures, for each DAF, teams of two persons searched for a matching HTC form (usually pink or 
white copies) included in the binders or envelopes.  Forms were matched by name and unique HTC form 
number.  If a matching form was located, the white and pink copies of the HTC form were examined for 
documentation of calls between facility staff and client. 
 
Appointment and call registers were next searched for all assigned DAFs.  Data abstractors worked in 
teams of two to examine register dates two weeks before and two weeks after the client’s appointment 
at that facility.   For each page in the register during this four-week interval, data abstractors searched 
for the client name of the assigned DAFs.  Located matching HTC forms, names in the appointment or 
call register within the four-week interval, and documentation of appointment-reminder or missed-
appointment telephone calls was used to complete Section C of the assigned DAF (Appendix D).  
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Evaluation of Enrollment and Retention Outcomes 
To evaluate enrollment and retention outcomes, abstraction teams focused on locating the chronic care 
file for each assigned DAF.  The chronic care file was the primary data source from which enrollment and 
retention data were abstracted.  Only if the chronic care file could not be located were data abstracted 
from other facility records (e.g., EMR or register).  Searches began by querying the facility’s EMR (if 
available) using combinations of the client’s first name, surname, and date of birth.  If the EMR search 
yielded a record that at least partially matched the client’s name, abstraction teams asked for or 
assisted facility staff to obtain the chronic care file.  If a matching chronic care file was located, data 
from the file were abstracted onto Sections D and E of the DAF (Appendix D).   
 
Assigned DAFs that did not yield a match on the EMR search were then reviewed by available expert 
clients, counselors, or nurses.  If names were recognized by facility staff, corresponding chronic care files 
were located and matched with client identifiers; data on matching clients were then abstracted onto 
DAFs.  For remaining un-matched DAFs, at most facilities, abstraction teams next searched through all of 
the chronic care files to identify potentially matching clients.  At some facilities, the number and 
methods by which chronic care files were stored prohibited comprehensive searches of all chronic care 
files.  Depending on the filing system, a targeted approach was used to search through chronic care files 
(e.g., files arranged alphabetically by client’s surname).   
 
If an assigned client’s chronic care file had not yet been located through the above procedures, data 
abstractors last conducted searches of names on paper registers.  Unless the client was located, a 
minimum of three primary registers had to be reviewed in accordance with standard procedures from 
the date of the client’s HIV diagnosis through the date of register review.  These registers included 
appointment, pre-ART, and ART registers.   If one or more primary registers were unavailable, secondary 
laboratory or pharmaceutical registers were reviewed for those time periods that the primary registers 
were unavailable.   
 
To review registers, data abstractors also worked in teams of two.  No more than two client names 
could be searched at one time by an abstractor, and each team could only search for the same two 
names. The intent of these methods was to ensure at least two persons searched for each assigned 
client to minimize the risk of missing a matching name recorded on a register.  In searching for names on 
the registers, the two team members had to review each page of the register, beginning from the 
earliest date of HIV diagnosis for the set of searched clients through the date of register review.  
Typically, two teams of two could review a register, page-by-page, at any one time.   
 
If at any point during the search a partial match was identified, the chronic care file was located and 
reviewed.  If a partial match was resolved to a match, data was abstracted from the file onto the DAF.  
Field supervisors had to review and resolve all partial matches as either a non-match or a match.  If the 
chronic care file could not be located, relevant data was transcribed from the matching data source—
typically the EMR, or pre-ART or ART register. 
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Teams also recorded any indication that a client initially referred to that facility was potentially enrolled 
at an alternate facility.  In the event this occurred, an abstraction team was sent to the alternate facility 
to initiate a full search and abstract data in accordance with the above procedures.  Before leaving the 
facility, field supervisors completed the data source form, and conducted brief interviews with the chief 
medical officer, administrator, or facility designee(s) to complete the clinic characteristics form. 
 
Component II 
Study interviewers created a DTF for eligible Component II clients by transcribing identifiers and client 
referral information from the DAF.  To reach clients, a minimum of three call attempts were made to the 
client or their next of kin.  Each call was made on a different day and at varied times to increase the 
likelihood of contacting the client.  
 
Once contact was made, interviewers verified the client’s identity and read a script that explained the 
purpose of the phone call and its sanction by the Swaziland Ministry of Health (Appendix G).  If 
permitted by the client, the consent form was read verbatim and clients were asked if they had any 
questions about the purpose of the study and if they would consent to the brief telephone interview.  If 
consent was obtained, interviewers administered the questionnaire and recorded responses onto the 
DTF in accordance with standard procedures.  Appointments for call backs were scheduled if the client 
was reached but unable to participate at that time. 
 
If contacted clients reported having enrolled at the facility to which they were referred, then data-
abstraction teams returned to those facilities and a new search was conducted.  Conversely, if clients 
reported having enrolled in care at a facility other than where they were referred (alternate facilities), 
data-abstraction teams visited those facilities and searched clinic records and abstracted data in 
accordance with Component I procedures.  If applicable, clients were asked their reasons for enrolling in 
a facility different from the referral facility or their reasons for never enrolling in HIV care.  Clients who 
reported never enrolling in care were encouraged to enroll and were offered assistance with locating a 
convenient HIV care facility that met their needs.  If assistance was accepted, the facility where the 
client wished to enroll was contacted by study personnel and an appointment was made for the 
requested date and time.   
 
Data Entry & Management 
After quality assurance review procedures were conducted (below), approved completed DAFs, CCFs, 
and DTFs were double-data entered into CSPro v5.0 on a secure server by trained data specialists.  All 
DSFs were single-data entered onto an Excel spreadsheet by the deputy project coordinator.  All 
completed study forms were maintained at ICAP Swaziland in locked filing cabinets in an access-
controlled room.   
 
Study Personnel & Training  
Study personnel included one project coordinator, one deputy project coordinator, one facility 
coordinator, five field supervisors, twenty-one data abstractors, one data management supervisor, and 
two data entry specialists (Appendix H).   Component I staff were trained during a five-day workshop on 
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standard operating procedures to identify and search facility data sources, locate and accurately match 
facility records with client HTC forms and DAFs, and abstract enrollment and retention data from chronic 
care files.  Training consisted of both didactic and practical sessions.  Data abstractors were subject to 
daily evaluations and had to pass a final matching and data-abstraction exercise to be hired.     
 
Two EC counselors were hired as interviewers and were trained over 10 days on Component II standard 
operating procedures.  Interviewers were required to role play multiple response scenarios to ensure 
they were prepared to mitigate a range of potential negative responses, administer the consent form 
and questionnaire in accordance with standard procedures, and accurately code client responses.  A 
team of two data specialists were also hired and trained over 3 days on data-management standard 
operating procedures.  These procedures specified how to enter data from study forms, perform daily 
reconciliations of double-entered data, upload and secure project databases, and perform quality 
assurance activities as described below.  
 
Quality Assurance 
Quality assurance procedures were employed throughout the study to ensure to the extent possible 
that (1) records of clients who enrolled at HIV care facilities were located and accurately matched with 
study HTC and data-abstraction forms, (2) that abstracted data were accurately transcribed from 
matching facility records onto study forms, and (3) that all completed forms were accurately entered 
into the project database.  To meet these objectives, quality assurance procedures included (1) multi-
level form reviews, tracking, and weekly briefings, (2) manual and automated database reviews, (3) 
enrollment and data-abstraction validations, and (4) database validations. 
 
1.  Form Reviews and Briefings 
Facility-based reviews.  In accordance with standard procedures, team supervisors reviewed all 
completed DAFs at facilities to confirm that records matched those of selected clients, that each 
abstracted DAF was complete and legible, and that transcribed data matched that of the original data 
source.  After conducting their review and correcting any observed errors, team leaders signed and 
attached a quality assurance tracking sheet to each DAF and submitted approved DAFs and DSFs for 
office review. 
 
Office-based reviews.  The data management supervisor and deputy project coordinator conducted 
independent reviews of submitted DAFs, CCFs, and DTFs evaluating completeness, legibility, and logic 
consistency of selected variables (e.g., chronology of dates).  Forms with errors were returned to the 
field supervisor, facility coordinator, or Component II interviewer for corrections.  For forms without 
observed errors, the deputy project coordinator and data management supervisor signed the quality 
assurance tracking sheet and submitted the form for data entry.  Finally, at data entry, records that 
failed data entry specialist reviews or automated checks for completeness, valid-values, and logic in the 
data entry applications were returned to the deputy project coordinator for further review and potential 
correction. 
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Briefings.  Weekly briefings attended by all study personnel were held to discuss challenges observed at 
facilities and common data errors.  When necessary, the briefings were used to conduct refresher 
trainings of standard operating procedures and problem solving of observed challenges. 
 
2.  Database Reviews 
Manual and automated reviews of the study database were carried out in the last month of data 
collection to assess the extent to which abstracted data were complete and logically consistent, and to 
resolve missing or inconsistent data.  Client records were identified that had key fields missing (e.g., CD4 
test results, WHO staging, ART initiation, etc.) or inconsistent data (e.g., out-of-chronology dates).  
Hardcopy DAFs were re-reviewed and errors resolved using information in the DAF comment field 
(which often explained the discrepancy).  If key missing or inconsistent data were not resolvable based 
on these reviews, the DAF, CCF, or DSF was re-sent to the appropriate facility for correction.  Corrected 
forms were reviewed and double-data entered in accordance with standard procedures; forms with 
discrepancies that could not be corrected were noted as not correctable.   
 
3.  Enrollment and Data Abstraction Validations 
Data abstraction teams led by the deputy project coordinator or CDC investigators were re-deployed to 
select facilities to (1) assess correct matching of clinic records and, of matched clients, the accuracy of 
transcribed data; (2) locate and abstract records of clients who had reportedly enrolled at that facility 
but had not been located previously; and (3) locate and abstract records of clients who had not been 
located previously and could not be contacted during Component II.  Updated or corrected DAFs were 
reviewed and double-data entered in accordance with standard procedures; forms with discrepancies 
that could not be corrected were noted as not correctable. 
 
4.  Database Validations 
A two-stage validation of the project database was conducted to assess the completeness and accuracy 
of data entry.  First, all hardcopy DAFs, CCFs, DSFs, and DTFs were located, reviewed, and compared 
against the electronic database to ensure a matching record existed in the electronic database.  Second, 
all recorded variable values of a random 10% sample of DAFs, DTFs, and CCFs were compared against 
corresponding variable values of electronic records.  Corrected forms were reviewed and double-data 
entered in accordance with standard procedures.  Finally, because DSFs were not double-data entered 
into the Excel database, all recorded values on DSFs were compared against those in the electronic 
database.  
 
Data Analysis 
Analytic Software and Restrictions 
SAS 9.3 (SAS Institute Inc., Cary, NC, USA) was used to evaluate all study objectives and Microsoft Excel 
was used to analyze data collected as part of the quality-assurance database validations.  SAS analyses 
were restricted to the sample of eligible SHIMS clients >17 years of age and SOKA clients >14 years of 
age.  Clients who were originally eligible but who were discovered at HIV care facilities to have been 
previously HIV diagnosed were excluded from analyses.   
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Levels of Analysis & Statistical Tests 
Findings are reported at two levels: facility and individual.  Facility-level characteristics are reported for 
enrollment and non-enrollment facilities separately, and for all facilities combined.  Individual-level 
characteristics are reported for the three study-gender groups separately: SHIMS females, SHIMS males, 
and SOKA males, and for all groups combined.  Findings are reported as percentages for nominal and 
ordinal variables (e.g., type of facility and WHO clinical staging, respectively), and as medians and 
interquartile ranges (Q1-Q3) for ratio-scaled variables (e.g., age and CD4 count).  Group differences 
were evaluated with the chi-squared (and t-test (t) statistics for categorical and ratio-scaled 
variables, respectively.  Kaplan Meier analyses were conducted to evaluate time to enrollment in HIV 
care.  The log-rank (LR) test was used to evaluate differences in survival functions.   For all analyses, p-
values (P) < 0.05 were considered statistically significant.   
 
Content & Sequence of Findings 
All principal objectives of this study were evaluated and findings in this report are presented in the 
following sequence: (1) Component I and II Study Periods; (2) Client and Referral Facility Characteristics; 
(3) Sample Description; (4) Implementation of National Linkage Procedures; (5) Client Interviews; (6) 
Enrollment in HIV care; (7) Baseline Clinical Characteristics; (8) ART Initiation; (9) Retention in HIV Care; 
(10) TB Screening and Cotrimoxazole Prescription; (11) Availability of Primary Data Sources; and (12) 
Quality Assurance. 
 
Enrollment in HIV Care 
Enrollment in HIV care was defined as documentation of either (1) having been clinically staged at an 
HIV care facility using the World Health Organization (WHO) HIV staging criteria, or (2) having received 
services at an HIV care facility at least once after the date a CD4 test was conducted.  Thus, for the 
purposes of this report, enrollment in care presumes clients were informed of their ART-eligibility status 
based on WHO stage or CD4-count result.  Unless otherwise indicated, enrollment in HIV care in this 
report was “verified” by data abstractors, supervisors, and CDC investigators in accordance with the 
above procedures.  Enrollment outcomes that were not 100% verified are noted as either “self-report” 
or “adjusted for non-response.”    
 
Enrollment in HIV care adjusted for non-response was estimated because study personnel were unable 
to interview all clients who were not initially verified as having enrolled in HIV care at facilities to which 
they were referred.  The overall adjusted enrollment-in-care rate was estimated by (1) applying the age-
group-specific, verified enrollment-in-care probabilities of clients interviewed in Component II, to the 
corresponding age-group distribution of Component II eligible clients who were not interviewed (sum of 
products = estimated enrolled clients); and (2) dividing the sum of estimated and verified enrolled 
clients by the total sample size.  Adjusted time-period-specific enrollment-in-care rates (e.g., 6 months 
after diagnosis) were estimated by applying the distribution of verified enrolled clients by time-period, 
to estimated enrolled clients, and dividing the sum of the estimated and verified enrolled clients for 
each time period by the total sample size.  
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Retention in Pre-ART and ART Care 
Retention was evaluated separately for pre-ART and ART clients in 6-month intervals (observation 
periods) after enrollment in HIV care (pre-ART retention) or after ART initiation (ART retention).  To be 
eligible for retention analyses, the date of abstraction had to occur after the date the observation period 
ended for each client (e.g., 12 months after ART initiation).  The maximum observation period for 
retention analyses was 24 months, as too few clients were observed in pre-ART or ART care beyond 24 
months.    
 
For the set of clients eligible for analyses in each observation period, clients were coded as retained in 
accordance with the following definitions.  For pre-ART clients, retention in care was defined as having a 
documented visit at the facility within 151 days from the date of data abstraction.  In accordance with 
national treatment guidelines, the recommended interval of time between pre-ART care visits is 120 
days.22 For ART clients, retention in ART care was defined as having a documented visit at the facility 
within 90 days from the date of data abstraction.  This 90-day interval was chosen to match the 
definition of ART retention in the Swaziland national ART program evaluation.11 In accordance with 
national treatment guidelines, the recommended interval of time between ART-care visits is 30 days.22       
 
In accordance with the above definitions, clients not retained in HIV care were assigned a LTFU date as 
the date of the most recent HIV-care visit.  For the set of clients eligible for analyses in each observation 
period, if the LTFU date occurred before the end of a retention observation period (e.g., 12 months after 
ART initiation), the client was defined as not retained during that observation period.  For example, if a 
client was eligible for retention analyses for 6 and 12 month observation periods ending on 06/30/2013 
and 12/31/2013, respectively, and the client’s LTFU date was 09/01/2013, the client was defined as 
retained for the 6-month observation period and not retained for the 12-month observation period.   
 
ART clients who were in pre-ART care for at least 6 months were also included in pre-ART retention 
analyses.   For these clients, if ART initiation occurred after the end of a pre-ART observation period 
(e.g., 6 months after enrollment), the client was defined as retained during that pre-ART observation 
period.  ART clients were excluded from pre-ART retention analyses if ART initiation occurred during or 
before a pre-ART care observation period.  For example, if a client enrolled in care on 01/01/2013 and 
was initiated on ART on 09/01/2013, then the client was defined as retained in pre-ART care for the first 
6-month observation period for pre-ART care.  The client was also excluded from all subsequent pre-ART 
retention analyses (e.g., 12-, 18-, and 24-month pre-ART observation periods).   
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Results 
 
1.  Component I and II Study Periods  
Final IRB approval of Component I was received on July 25, 2013 and study personnel initiated data-
abstraction visits to the 69 referral facilities on September 18, 2013.  Final IRB approval of Component II 
was received on October 31, 2013 and study personnel initiated telephone interviews on December 3, 
2013.  Telephone interviews were completed on January 23, 2014 and data-abstraction visits at facilities 
were completed on February 11, 2014.  Study personnel visited a total of 92 facilities as part of 
Components I & II (Appendix I).  Of these 92 facilities, 69 were facilities to which all participants were 
referred to care at HIV diagnosis, 20 were identified from clients interviewed during Component II, and 3 
were uniquely identified as part of Component I activities (e.g., facilities that medical records or study 
personnel indicated as likely enrollment facilities).  Finally, study personnel conducted data abstraction 
validation visits at facilities from January 27, 2014 to February 13, 2014, at which point all data 
collection activities ended.  
 
2.  Sample Description 
In August 2014, study personnel from MOH, PSI, and CDC visited 13 SOKA sites located in each of the 
four regions of Swaziland to locate and review all archived HTC forms of males >14 years of age who 
sought MC services and who tested HIV-positive during the Soka Uncobe campaign.  Review of all 
archived SOKA HTC forms at these sites identified 389 initially eligible SOKA clients (Figure 1).  Of these, 
44 were referred to HIV care facilities that had less than three SOKA referrals and were excluded from 
the study.  Of the 345 clients referred to eligible facilities, 28 (8.1%) were identified at facilities to have 
been in HIV care before their SOKA HIV test date.  These 28 ineligible clients were excluded from 
analyses, leaving an analytic sample size of 317 male SOKA clients (Figure 1). 
 
During August and September 2014, study personnel from ICAP and CDC reviewed all HTC forms of 
SHIMS participants who tested HIV-positive that were archived at the ICAP country office.  Review of 
archived forms identified 850 initially eligible SHIMS clients (Figure 1).  During data abstraction, 62 
(7.3%) clients were identified at facilities to have been in HIV care before their SHIMS HIV test date.  
Records from these 62 clients were excluded from analyses, leaving an analytic sample size of 788 
SHIMS clients (494 females, 294 males).   
 
The combined sample of 1,105 eligible SHIMS and SOKA clients were referred to 69 HIV care facilities 
located in the four regions of Swaziland (16-18 facilities each) (Figure 2).  Although the percentage of 
referral facilities was similar by region (23.2% - 26.1%), proportionally more clients were referred to 
facilities in Hhohho and Manzini (31.8% and 31.0%, respectively) than clients referred to facilities in 
Shiselweni and Lubombo (21.7% and 15.6%, respectively) (Figure 1).  
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Figure 1.  Distribution of eligible newly HIV diagnosed SHIMS and Soka Uncobe clients referred to health 
facilities in the four regions of Swaziland, 2011-2012.  
 
 
Figure 2. Distribution of 69 HIV care facilities to which eligible SHIMS and Soka Uncobe clients were 
referred at HIV diagnosis, by class of facility, 2011-2012. 
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4.  Client and Referral Facility Characteristics 
Study Groups Combined 
Table 1 includes findings on client and referral facility characteristics, by study-gender group.  Of the 
1,105 eligible clients, the median (Q1-Q3) age at HIV diagnosis was 29 years (24-35).  At the time of their 
HIV diagnosis, clients were predominantly referred to government-operated facilities (71.4%), and 
facilities classified as clinics (47.4%) and hospitals (34.4%); 14.8% of clients were referred to facilities 
operated by private or non-government organizations, or the Swaziland military.   Similar proportions of 
clients were referred to facilities in urban and rural areas (42.9-42.0%).  All clients were referred to 
facilities that provided ART refills on site (100%), and nearly all were referred to facilities which initiated 
ART (98.6%) and had phones (95.6%) and monthly airtime credit [median (Q1-Q3) Swaziland 
emalangeni: 150 (150-200)] available to implement the National SOP (Table 1).    
 
Study Group Similarities & Differences 
SHIMS females were younger than SHIMS males (t = -8.44; P < 0.0001) and SOKA males (t = -4.46; P < 
0.0001) (Table 1).  All characteristics of referral facilities were similar for SHIMS males and females.  
Compared with SHIMS clients, SOKA clients were less likely to be referred to a government facility ( = 
140.7; P < 0.0001), and were more likely to be referred to an urban facility ( = 60.1; P < 0.0001) and a 
facility located on a paved road (= 43.3; P < 0.0001) (Table 1).  Similar proportions of clients in all 
study-gender groups were referred to facilities with the same HIV clinical-services characteristics (Table 
1).  
 
 
Table 1. Client and referral facility characteristics, by study-gender group. 
 
 
Characteristic  
SHIMS  
Female 
(N=494) 
SHIMS  
Male 
(N=294) 
SOKA 
Male 
(N=317) 
 
All Clients 
(N=1105) 
Age at diagnosis, median ( Q1-Q3) 26 (22 – 33) 32 (27 – 38) 29 (25 – 35) 29 (24 – 35) 
Age at diagnosis (years)     
    <25  204 (41.3%)   37 (12.6%)   58 (18.3%) 299 (27.1%) 
    25-29 122 (24.7%)   72 (24.5%) 105 (33.1%) 299 (27.1%) 
    30-35   81 (16.4%)   84 (28.6%)   87 (27.4%) 252 (22.8%) 
    >35   87 (17.6%) 101 (34.3%)   67 (21.1%) 255 (23.1%) 
Region of referral facility     
     Hhohho 148 (30.0%) 101 (34.4%) 102 (32.2%) 351 (31.8%) 
     Lubombo   83 (16.8%)   51 (17.4%)   38 (12.0%) 172 (15.6%) 
     Manzini 135 (27.3%)   81 (27.6%) 126 (39.8%) 342 (31.0%) 
     Shiselweni 128 (25.9%)   61 (20.8%)   51 (16.1%) 240 (21.7%) 
Type of referral facility      
     Government (non-military) 369 (74.7%) 231 (78.6%) 189 (59.6%) 789 (71.4%) 
     Faith-based   91 (18.4%) 39 (13.3%) 23 (7.3%) 153 (13.9%) 
     Private 24 (4.9%)     15 (5.1%)   46 (14.5%) 85 (7.7%) 
     NGO  8 (1.6%) 4 (1.4%)   46 (14.5%) 58 (5.3%) 
     Military    2 (0.4%) 5 (1.7%) 13 (4.1%) 20 (1.8%) 
Class of referral facility      
     Hospital 166 (33.6%) 109 (37.1%) 105 (33.1%) 380 (34.4%) 
     Health Center 92 (18.6%)   43 (14.6%)   36 (11.4%) 171 (15.5%) 
     Clinic 227 (46.0%) 137 (46.6%) 160 (50.5%) 524 (47.4%) 
     PHU 9 (1.8%) 5 (1.7%) 16 (5.1%) 30 (2.7%) 
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Characteristic  
SHIMS  
Female 
(N=494) 
SHIMS  
Male 
(N=294) 
SOKA 
Male 
(N=317) 
 
All Clients 
(N=1105) 
 
Location of referral facility1 
    
     Urban 176 (35.6%) 110 (37.4%) 188 (59.3%) 474 (42.9%) 
     Peri-urban   66 (13.4%)   56 (19.1%)   45 (14.2%) 167 (15.1%) 
     Rural 252 (51.0%) 128 (43.5%)   84 (26.5%) 464 (42.0%) 
     
Referral facility on a paved road 370 (74.9%) 217 (73.8%) 292 (92.1%) 879 (79.6%) 
Days per week HIV services provided    
     Monday – Friday 353 (71.5%) 217 (73.8%) 232 (73.2%) 802 (72.6%) 
     Monday – Saturday  90 (18.2%)  45 (15.3%)   61 (19.2%) 196 (17.7%) 
     Monday – Sunday  51 (10.3%)  32 (10.9%) 24 (7.6%)       107 (9.7%) 
Change in days per week facility is open 
since March 2011 
    
     Increase 137 (27.7%)   96 (32.7%) 119 (37.5%)       352 (31.9%) 
     Decrease 31 (6.3%) 28 (9.5%) 26 (8.2%)         85 (7.7%) 
     No change 326 (66.0%) 170 (57.8%) 172 (54.3%)       668 (60.5%) 
Providers per HIV-clinic day, median(Q1–
Q3) 
    
     Doctors 1 (1 – 2) 1 (1 – 2) 1 (1 – 2)           1 (1 – 2) 
     Nurses 4 (2 – 6) 5 (2 – 6) 6 (4 – 8)           5 (2 – 6) 
     Counselors 0 (0 – 1) 0 (0 – 1) 0 (0 – 1)           0 (0 – 1) 
     Lay Counselors 0 (0 – 1) 0 (0 – 1) 0 (0 – 1)           0 (0 – 1) 
     Expert Clients 2 (2 – 3) 2 (2 – 3) 2 (1 – 3)           2 (2 – 3) 
     All cadres combined   8 (6 – 13)  9 (6 – 13) 10 (6 – 13)           9 (6 – 13) 
     
ART initiated at referral facility  487 (98.6%) 289 (98.3%) 314 (99.1%)       1090 (98.6%) 
     
ART refills provided at referral facility       494 (100%) 294 (100%) 317 (100%)       1105 (100%) 
Providers who initiate ART     
     Doctor only   57 (11.5%) 29 (9.9%) 25 (7.9%)         111 (10.1%) 
     Nurse only 153 (31.0%)   97 (33.0%)   94 (29.7%)        344 (31.1%) 
     Doctor and Nurse 277 (56.1%) 163 (55.4%) 195 (61.5%)        635 (57.5%) 
     N/A  7 (1.4%)   5 (1.7%)   3 (1.0%)          15 (1.4%) 
     
Phone available to implement National 
SOP2  
465 (94.1%) 279 (94.9%) 312 (98.4%)      1056 (95.6%) 
Monthly credit available to implement 
National SOP, median (Q1-Q3) 
SZL 150 
(150-200) 
SZL 150 
(150-200) 
SZL 150 
(150-300) 
       SZL 150 
     (150-200) 
Staff responsible for calling defaulters3      
     Doctors   0 (0.0%)   0 (0.0%)   0 (0.0%)           0 (0.0%) 
     Nurses 239 (48.4%) 141 (48.0%) 200 (63.1%)      580 (52.5%) 
     Counselors  8 (1.6%) 12 (4.1%) 13 (4.1%)        33 (3.0%) 
     Lay Counselor/EC 321 (65.0%) 194 (66.0%) 188 (59.3%)      703 (63.6%) 
1 Self-defined by providers interviewed on facility characteristics. 
2 Patient linkage, retention, and follow-up in HIV care standard operating procedures, Swaziland National AIDS Programme, 2012. 
3 More than one cadre could be responsible for calling clients who defaulted from their first or subsequent appointment to the HIV facility, in 
accordance with the National SOP. 
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4.  Implementation of National Linkage Procedures  
Linkage Service Expectations 
In accordance with the national linkage SOP, staff at the 69 referral facilities were expected to conduct 
the following four linkage procedures (% expectation of target population): (1) receive and store the 
pink copy of the HTC form (100% of referred clients), (2) record referred clients in the appointment 
register (100% of referred clients), (3) call or send SMS text appointment reminder to clients before their 
date of appointment (100% of referred clients who provided a telephone number and consented to 
follow-up contact), and (4) call clients approximately 3 days after their missed appointment (100% of 
clients who missed their appointment who gave a telephone number and consented to follow-up.)    
 
HTC Referral Forms and Enrollment Appointments  
Table 2 includes findings on the documented implementation of the above four procedures at referral 
facilities, by study-gender group, region, and facility characteristics.  Of the 1,105 clients referred to 69 
facilities, study personnel located 517 (46.8%) pink HTC forms and found that 106 (9.6%) clients had 
their enrollment appointment recorded in the appointment register at the referral facility (Table 2).  
Compared with corresponding subgroups, proportionally fewer copies of the pink HTC form were found 
for SOKA clients, and at referral facilities (1) located in Lubombo region, (2) typed as private, and (3) 
classified as health centers.  These subgroups were also less likely to have enrollment appointments 
documented in facility appointment registers (Table 2).   
 
Table 2.  Documented linkage procedures at referral facilities.1 
 
Characteristic 
N 
Pink Copy of HTC 
Form Located2  
Client Recorded in 
Appt. Register  
Client Called Before 
First  Appointment3 
Client Called After 
First Appointment4 
Total 1105 517 (46.8%) 106 (9.6%) 3 (0.3%) 54 (4.9%) 
Study-gender group      
     SHIMS Female    494 249 (50.4%) 52 (10.5%) 2 (0.4%) 29 (5.9%) 
     SHIMS Male   294 150 (51.0%) 34 (11.6%) 1 (0.3%) 19 (6.5%) 
     Soka Uncobe   317 118 (37.2%)       20 (6.3%) 0 (0.0%)   6 (1.9%) 
Facility region      
     Hhohho   351 200 (57.0%) 43 (12.3%) 2 (0.6%) 11 (3.1%) 
     Lubombo   172   46 (26.7%) 8 (4.7%) 1 (0.6%)   3 (1.7%) 
     Manzini   342 167 (48.8%) 41 (12.0%) 0 (0.0%)   39 (11.4%) 
     Shiselweni   240 104 (43.3%)           14 (5.8%) 0 (0.0%)   1 (0.4%) 
Facility type          
     Government    789 396 (50.2%) 98 (12.4%) 2 (0.3%) 50 (6.3%) 
     Faith-based   153   84 (54.9%) 6 (3.9%) 1 (0.7%)  3 (2.0%) 
     Private     85    8 (9.4%) 1 (1.2%) 0 (0.0%)  0 (0.0%) 
     NGO     58  16 (27.6%) 1 (1.7%) 0 (0.0%)  0 (0.0%) 
     Military     20   13 (65.0%) 0 (0.0%) 0 (0.0%)  1 (5.0%) 
Facility class      
     Hospital   380 217 (57.1%) 47 (12.4%) 1 (0.3%) 33 (8.7%) 
     Health Center   171   55 (32.2%) 7 (4.1%) 0 (0.0%)  1 (0.6%) 
     Clinic   524 219 (41.8%) 52 (9.9%) 2 (0.4%)            20 (3.8%) 
     PHU     30   26 (86.7%) 0 (0.0%) 0 (0.0%)   0 (0.0%) 
1These standard procedures were supposed to be implemented at all government health facilities during the time of the study in accordance with 
the national standard operating procedures for client linkage and retention.   
2 Sent from the HTC provider to the referral facility via the specimen transport network, then located by study staff at the facility. 
3 Of 3 total clients called before their appointment, facility staff spoke with 2. 
4 Of 54 total clients called after the appointment, facility staff spoke with 32.  
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Enrollment Appointment Reminder & Missed Appointment Calls 
Of the 1,105 clients, 789 (71.4%) provided a phone number and consented to follow-up contact on the 
day of their HIV diagnosis.  Study personnel found documentation that 3 (0.3%) were called before their 
first appointment (clinic staff spoke with 2 clients of the 3 called), and 54 (4.9%) were called within two 
weeks after their enrollment appointment (clinic staff spoke with 32 clients of the 54 called).  Analyses 
included all referred clients because some HTC forms that were not located at the time of data 
abstraction could have been available at the facility at the time linkage services should have been 
provided.  Of the 517 located pink HTC forms, 351 (67.9%) indicated that the client gave a telephone 
number and consented for follow-up contact.  Among these 351 clients, study personnel found 
documentation that 1 (0.3%) had been called before their enrollment appointment.   Of the 351 clients 
with located HTC forms, 333 (94.9%) did not enroll in HIV care within 21 days of their HIV diagnosis (7 
days after their estimated date of appointment).  Of these 333 clients who missed their enrollment 
appointment, study personnel found documentation that 27 (8.1%) were called within two weeks after 
their missed appointment.     
 
5.  Client Interviews 
Eligibility & Participation 
Of the 1,105 clients, 225 were initially verified to have enrolled in HIV care at the facility to which they 
were referred.  Of the 880 clients not initially verified to have enrolled at their referral facility, 641 
(72.8%) provided a telephone number and consented to follow-up contact at HIV diagnosis.  Of these 
Component II eligible clients, 322 (50.2%) were contacted, and 267 (41.7%) consented to and completed 
a telephone interview (Figure 3).  Of contacted clients, 55 (17.1%) refused to be interviewed.  Among 
the 880 clients not initially verified to have enrolled in care, interview rates (30.3%, 267/880) varied by 
age group among SHIMS females (age <25 years vs. >25 years, 18.6% vs. 33.3%;  = 10.2; P = 0.001), but 
not among SHIMS and SOKA males (age <25 years vs. >25 years, 36.6% vs. 32.0%;  = 0.64; P = 0.42); 
interview rates did not vary by region (range 28.2-31.9%;  = 1.0; P = 0.80). 
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Figure 3. Eligible newly HIV diagnosed SHIMS and Soka Uncobe clients verified to have enrolled in HIV 
care. 
 
 
Linkage Services Received 
Table 3 includes findings on self-reported linkage services received by interviewed Component II clients.  
Of the 267 interviewed clients, 251 (94.0%) recalled being referred to HIV care at the time of their HIV 
diagnosis in SHIMS or Soka Uncobe, and of these, 181 (72.1%) accurately reported the name of the 
referral facility on the HTC form to which they were referred (Table 3).  Of the 267 clients, few reported 
receiving linkages services from the referral facility: 21 (7.9%) reported receiving an SMS reminder of 
their appointment; 24 (9.0%) reported having received a phone call from the referral facility; 13 (4.9%) 
reported having a home visit from facility personnel; and 9 (3.4%) reported speaking to someone from 
the facility at their home (Table 3).   
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Table 3.  Self-reported linkage services received by clients whose enrollment in HIV care was not 
initially verified and who were successfully contacted and interviewed by phone.1  
 
Linkage Services Received 
SHIMS Females 
(n=105) 
SHIMS Males 
(n=71) 
Soka Uncobe 
(n=91) 
All Clients 
(n=267) 
Reported being referred to HIV care at 
diagnosis. 
102 (97.1%) 65 (91.6%) 84 (92.3%) 251 (94.0%) 
Accurately recalled the same referral facility 
noted on the HTC form.2 
74 (70.5%) 47 (66.2%) 60 (65.9%) 181 (67.8%) 
Received an SMS text reminder to enroll in HIV 
care. 
9 (8.6%) 5 (7.0%) 7 (7.7%) 21 (7.9%) 
Received a phone call from the referral facility 
to enroll in HIV care. 
8 (7.6%) 4 (5.6%) 12 (13.2%) 24 (9.0%) 
Received a home visit from a referral facility 
representative. 
      10 (9.5%) 3 (4.2%) 0 (0.0%) 13 (4.9%) 
Spoke at home with referral facility 
representative about enrolling in care. 
6 (5.7%) 3 (4.2%) 0 (0.0%) 9 (3.4%) 
1 Interviews were conducted a median (Q1-Q3) of 957 (914-992) days from diagnosis.  
2 Of the 251 clients who recalled being referred to care and treatment at the time of their diagnosis, 181 (72.1%) accurately reported the name of 
the facility where they had been referred. 
 
Self-reported and Verified Enrollment in Care 
Table 4 includes findings on self-reported and verified enrollment in care of interviewed Component II 
clients, by study-gender group.  Of 267 interviewed clients, 148 (55.4%) reported and 75 (28.1%) were 
verified as having enrolled in HIV care; 13 (4.9%) were verified at the referral facility and 62 (23.2%) 
were verified at an alternate facility (Table 4).  Of 267 interviewed clients, 15.0% (9/60), 28.2% (40/142), 
and 40.0% (26/65) were verified to have enrolled in HIV care among those aged <25 years, 25-35 years, 
and >35 years of age, respectively ( = 9.65; P = 0.008); verified enrollment in HIV care did not vary by 
study-gender group ( = 1.01; P = 0.60) and region ( = 0.91; P = 0.82). 
 
Reasons for Enrolling at an Alternate Facility 
Of clients who reported enrolling at an alternative facility, the four most common reasons for enrolling 
at the alternate facility (more than one reason could be given) included: (1) less transportation cost or 
greater convenience by living closer to that facility (64.9%); (2) greater trust in the providers or believing 
that the quality of care is better at the alternate facility (42.5%); (3) believing that health care staff are 
more respectful and less discriminatory (22.3%); and (4) believing that they have a shorter wait time at 
that facility (14.9%)(Table 4).  No differences were observed between the three groups in the relative 
order of these most common reasons (Table 4).   When restricted to the 75 clients who were verified to 
have enrolled at an alternate facility, the reported proportions and order of common reasons were 
similar (data not reported).   
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Table 4.  Self-reported and verified enrollment in HIV care of clients whose enrollment at referral 
facilities was not initially verified and who were successfully contacted and interviewed by phone.1 
 
Enrollment in HIV care 
SHIMS 
Females 
(n=105) 
SHIMS Males 
(n=71) 
Soka  
Uncobe  
(n=91) 
 
All Clients 
(n=267) 
Self-reported ever enrolled in HIV care      
     Referral facility 26 (24.8%) 11 (15.5%) 14 (15.4%)   51 (19.1%) 
     Alternate facility 37 (35.2%) 24 (33.8%) 36 (39.6%)   97 (36.3%) 
     Any facility 63 (60.0%) 35 (49.3%) 50 (55.0%) 148 (55.4%) 
 
Verified enrollment in HIV care 
    
     Referral facility 7 (6.7%) 2 (2.8%) 4 (4.4%) 13 (4.9%) 
     Alternate facility 21 (20.0%) 16 (22.5%) 25 (27.5%)   62 (23.2%) 
     Any facility 28 (26.7%) 18 (25.4%) 29 (31.9%)   75 (28.1%) 
     
Clients who enrolled at alternate facility2 n=35 n=23 n=36 n=94 
     Reasons for enrollment at alternate facility3     
         Lives closer4  24 (68.6%) 19 (82.6%) 18 (50.0%) 61 (64.9%) 
         Receives better care5  14 (40.0%) 12 (52.2%) 14 (38.9%) 40 (42.6%) 
         Health care staff are more respectful6     6 (17.1%)   6 (26.1%)   9 (25.0%) 21 (22.3%) 
         Shorter wait to see a provider7    4 (11.4%) 2 (8.7%)   8 (22.2%) 14 (14.9%) 
         Greater anonymity8  2 (5.7%) 1 (4.3%) 3 (8.3%) 6 (6.4%) 
         More familiar with facility9       3 (8.6%) 0 (0.0%) 1 (2.8%) 4 (4.3%) 
         Other reason  1 (2.9%) 0 (0.0%) 3 (8.3%) 4 (4.3%) 
1 Interviews were conducted a median (Q1-Q3) of 957 (914-992) days from diagnosis. 
2 Clients who reported one or more reasons for enrolling at an alternate facility.   
3 Response options were not provided to clients; more than one reason could be given.  
4 Lives closer; transportation to alternate facility is less expensive. 
5 Receives better care; has greater trust in the providers. 
6 Health care staff are more respectful; health care staff at referral facility discriminate. 
7 Shorter wait time to receive services; services are available on the weekends. 
8 Greater confidentiality; does not know people at the facility; lives further away from the facility. 
9 More familiar with the facility; knows people at the facility. 
 
Reasons for not Enrolling in Care 
Of the 267 clients interviewed during Component II, 119 (44.6%) reported having never enrolled in HIV 
care.  These 119 clients were interviewed a median (Q1-Q3) of 956 days (902-992) after their HIV 
diagnosis.  Of 116 clients who provided reasons for not enrolling in HIV care (Table 5), the four most 
common reasons included: (1) feeling well and believing they didn’t need to go to an HIV clinic (50.9%); 
(2) being too busy or not having the time for HIV care (37.1%); (3) believing they would have to wait too 
long to see providers at HIV care facilities (18.1%); and (4) that HIV care facilities were either too far 
away or travel costs were too high (13.8%).  No differences were observed between the three study-
gender groups in the relative order of these most common reasons for never enrolling in HIV care (Table 
5).  Few clients reported the following reasons for never enrolling in HIV care: concerns about ART or the 
quality of HIV care, belief that staff at facilities are not respectful, and not being HIV-positive (five clients 
reported that they did not know their HIV status and five reported that they had re-tested and were 
HIV-negative).   
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Table 5.  Reasons for not enrolling in HIV care reported by clients whose enrollment at referral facilities 
was not verified and who were successfully contacted and interviewed by phone.1 
 
 
Reasons2 
 
SHIMS 
Females 
(n=42) 
 
SHIMS Males 
(n=36) 
Soka  
Uncobe  
(n=38) 
 
All Clients3 
(n=116) 
Feeling well, no need to go to HIV clinic  21 (50.0%) 15 (41.7%) 23 (60.5%) 59 (50.9%) 
Too busy, no time 18 (42.9%) 14 (38.9%) 11 (28.9%) 43 (37.1%) 
Has to wait too long to see a provider    5 (11.9%)   7 (19.4%)   9 (23.7%) 21 (18.1%) 
Facility too far away / travel too expensive  4 (9.5%)   8 (22.2%)   4 (10.5%) 16 (13.8%) 
Staff at health facilities are disrespectful 4 (9.5%) 2 (5.6%) 3 (7.9%) 9 (7.8%) 
Negative opinion of ART4  1 (2.4%) 3 (8.3%) 1 (2.6%) 5 (4.3%) 
Poor quality of care at health facilities5 3 (7.1%) 0 (0.0%) 1 (2.6%) 4 (3.4%) 
Wants to remain anonymous6 3 (7.1%) 0 (0.0%) 2 (5.3%) 5 (4.3%) 
Does not know HIV status7  3 (7.1%) 1 (2.8%) 1 (2.6%) 5 (4.3%) 
Retested HIV negative  2 (4.8%) 2 (5.6%) 1 (2.6%) 5 (4.3%) 
No one followed up after diagnosis  0 (0.0%) 1 (2.8%)   4 (10.5%) 5 (4.3%) 
Other reason 1 (2.4%) 2 (5.6%) 3 (7.9%) 6 (5.2%) 
1 Of 267 clients interviewed, 119 reported not having enrolled in HIV care.  These 119 clients were interviewed a median (Q1-Q3) of 956 days 
(902-992) after their HIV diagnosis.  
2 Response options were not provided to clients; more than one reason could be given.  
3 Clients who reported one or more reasons for not having enrolled in HIV care. 
4 Does not believe HIV treatment is effective; believes HIV treatment has severe side effects; fears ART, being treated by a traditional healer. 
5 Poor quality of HIV care; does not trust HIV care providers. 
6 Does not want others to know HIV status; not yet disclosed status to partner; fears separation from spouse or partner. 
7 Did not receive HIV test results. 
 
Interest in Enrolling in Care 
Of the 119 clients who reported having never enrolled in care, study personnel asked if they would like 
to enroll in care and whether they would accept an appointment and referral to an HIV care facility; 87 
(73.1%) clients responded that they would like to enroll in HIV  care and 78 (65.6%) accepted the 
appointment.  Because the study protocol did not explicitly permit tracing these newly referred clients 
to HIV care, the percentage of clients who subsequently enrolled is unknown.  
 
6.  Enrollment in HIV Care 
Verified Enrollment in HIV Care 
Study personnel visited 92 facilities to verify enrollment, 69 referral and 23 alternate (Appendix I).  At 
least one client was verified to have enrolled in each of 78 facilities: 61 (88.4%) referral and 17 (73.9%) 
alternate.  Thus, 86 facilities were available for individual-level analyses including 78 facilities with at 
least one enrollment and 8 referral facilities without any enrollments (for clients not enrolled in care, 
the referral facility was selected for analyses).  The 86 facilities were equally distributed in the four 
regions (range: 22.1%-27.9%), and included 72 clinics, 8 hospitals, 5 health centers, and 1 public health 
unit.  Of 1,105 clients, study personnel verified that 300 (27.2%) enrolled in HIV care (Figure 3); 136 
(27.5%) SHIMS females, 73 (24.8%) SHIMS males, and 91 (28.7%) SOKA males.  Of those enrolled in 78 
facilities, white referral forms were located for 53 (17.7%) clients, and medical charts were located and 
used for data abstraction on 266 (88.7%).  Of the remaining 34 clients, pre-ART or ART registers (n=21) 
and electronic medical records (n=13) were used for data abstraction. 
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Client Correlates.  Overall, 100 (9.1%), 124 (11.2%), 174 (15.8%), 221 (20.0%), and 265 clients (24.1%, 
including censored observations) were verified to have enrolled within 3, 6, 12, 18, and 24 months of 
diagnosis, respectively.  Kaplan Meier survival (enrollment-in-care) functions did not vary by region (LR = 
0.73; P = 0.87), but varied by age-group (LR = 18.39; P = 0.0004) (Figures 4, 5).  Clients >35 years of age 
were more likely to enroll in care compared with those 14-24 (LR = 14.74; P = 0.0001) and 25-29 (LR = 
10.60; P = 0.001) years of age.  Kaplan Meier functions indicating higher enrollment probability among 
older age groups remained statistically significant when controlling for region, urban/rural location of 
facility, and study-gender group (data not shown).  Taking censoring into consideration, within two years 
of diagnosis, 18.8%, 21.2%, 26.3%, and 31.4% of clients 14-24, 25-29, 30-35, and >35 years of age, 
respectively, enrolled in care.  Differences in enrollment by study-gender group depended on time since 
diagnosis (Figure 6).  Proportionally more SOKA than SHIMS clients enrolled in care 90 and 182 days 
after diagnosis (90 days, 13.2% vs. 7.4%; ( = 9.48; P = 0.002; 182 days, 15.5% vs. 9.5%; ( = 7.96; P = 
0.005); at 600 days after diagnosis prior to the first censored observation, no differences were observed 
between SOKA and SHIMS clients ( = 0.15; 21.8% vs. 20.7%; P = 0.70) (Figure 6).   
 
 
 
Figure 4.  Cumulative verified enrollment in HIV care, by region of facility. 
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Figure 5.  Cumulative verified enrollment in HIV care, by age group (years). 
 
 
Figure 6.  Cumulative verified enrollment in HIV care, by study-gender group. 
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Facility Correlates.  Kaplan Meier functions varied by facility classification among both SHIMS males (LR = 
18.47; P < 0.0001) and females (LR = 6.09; P = 0.014) (Figures 7, 8), but not among SOKA males (LR = 
0.45; P = 0.50) (data not shown).  Among SHIMS males, enrollment in hospitals and health centers was 
particularly low (Figure 7).  Kaplan Meier functions indicating greater clinic enrollment probability 
among SHIMS clients remained statistically significant when controlling for age-group, region, 
urban/rural facility location, and after restricting the analysis to referral facilities alone (data not shown).   
Of clinics located in rural and peri-urban areas only (clinics on paved roads, n=20; clinics on dirt roads, 
n=34), enrollment in care among SHIMS clients (n=311) was greater in those clinics located on dirt roads 
(LR = 8.01; P = 0.005) (Figure 9).  Analyses were restricted to SHIMS because few SOKA clients were 
referred to or enrolled in clinics served by dirt roads.  Kaplan Meier functions indicating greater 
enrollment probability in clinics on dirt roads remained statistically significant after controlling for 
gender and restricting the analysis to referral facilities alone (data not shown).   
 
 
 
Figure 7.  Cumulative verified enrollment in HIV care, by type of health facility, SHIMS male clients only. 
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Figure 8.  Cumulative verified enrollment in HIV care, by type of health facility, SHIMS female clients only. 
 
 
Figure 9.  Cumulative verified enrollment in HIV clinics located in rural and peri-urban areas, by road 
condition serving the clinic, SHIMS clients only. 
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Facility Characteristics 
Table 6 includes findings on the characteristics of those facilities in which clients were verified as having 
enrolled in HIV care.  Of the 300 clients who enrolled in HIV care, most enrolled at facilities that were 
government operated (72.7%), designated as clinics (59.0%) or hospitals (27.7%), accessed by paved 
roads (69.3%), and located in Hhohho (31.7%) and Manzini (29.3%), and in rural (49.7%) locations (Table 
6).  Although most clients enrolled at the facility to which they were referred, a large minority (28.0%) 
enrolled at alternate facilities.  Compared with SHIMS clients, proportionally more SOKA clients enrolled 
at facilities that were non-governmental ( = 40.4; P < 0.0001), located in urban areas ( = 33.9; P < 
0.0001), designated as hospitals ( = 15.0; P = 0.02), and accessed by a paved road ( = 23.4; P < 
0.0001) (Table 6).   
 
Table 6.  Facility characteristics of clients enrolled in HIV care, by study-gender group.  
 
Characteristic 
SHIMS Females 
(n=136) 
SHIMS Males 
(n=73) 
Soka Uncobe 
(n=91) 
All Clients1 
(n=300) 
Enrollment Facility2      
    Referral  104 (76.5%) 48 (65.8%) 64 (70.3%) 216 (72.0%) 
    Alternate    32 (23.5%) 25 (34.3%) 27 (29.7%)   84 (28.0%) 
Region of enrollment facility     
     Hhohho 44 (32.4%) 20 (27.4%) 31 (34.1%) 95 (31.7%) 
     Lubombo 22 (16.2%) 13 (17.8%) 14 (15.4%) 49 (16.3%) 
     Manzini 34 (25.0%) 19 (26.0%) 35 (38.5%) 88 (29.3%) 
     Shiselweni 36 (26.5%) 21 (28.8%) 11 (12.1%) 68 (22.7%) 
Facility type         
     Government 109 (80.2%) 59 (80.8%) 50 (55.0%) 218 (72.7%) 
     Faith-based   18 (13.2%) 4 (5.5%) 12 (13.2%)   34 (11.3%) 
     Private  8 (5.9%)   9 (12.3%) 15 (16.5%)   32 (10.7%) 
     NGO 1 (0.7%) 0 (0.0%) 11 (12.1%)    12 (4.0%)  
     Military 0 (0.0%) 1 (1.4%) 3 (3.3%)              4 (1.3%) 
Facility class     
     Hospital 35 (25.7%) 14 (19.2%) 34 (37.4%) 83 (27.7%) 
     Health Center 24 (17.7%) 7 (9.6%) 7 (7.7%) 38 (12.7%) 
     Clinic 75 (55.2%) 52 (71.2%) 50 (55.0%)         177 (59.0%)  
     PHU 2 (1.5%) 0 (0.0%) 0 (0.0%)             2 (0.7%) 
Facility location3     
     Urban 35 (25.7%) 18 (24.7%) 50 (54.9%) 103 (34.3%) 
     Peri-urban 16 (11.8%) 15 (20.5%) 17 (18.7%)   48 (16.0%) 
     Rural 85 (62.5%) 40 (54.8%) 24 (26.4%) 149 (49.7%) 
Facility access     
     Paved road 88 (64.7%) 40 (54.8%) 80 (87.9%) 208 (69.3%) 
     Dirt road 48 (35.3%) 33 (45.2%) 11 (12.1%)   92 (30.7%) 
1 Enrollment at any HIV care facility; 225 enrolled clients verified during Component I and 75 verified during Component II. 
2 Referral facility: an HIV care facility to which clients were referred at HIV diagnosis; alternate facility: any HIV care facility except the referral facility.  
Fifteen clients met the definition of enrolled at both the referral facility and an alternative facility; assignment to one of the two facilities as the location 
of initial enrollment was based on the earliest date of enrollment.  
3 Self-defined by providers interviewed on facility characteristics.  
 
Enrollment in HIV Care Adjusted for Non-response 
Of the 613 clients who were not initially verified to have enrolled in care and not interviewed (<25 years, 
n=183; 25-35 years, n=305; >35 years, n=125), 164 are estimated to have enrolled in HIV care by 
applying age-group-specific verified enrollment probabilities of interviewed clients (<25 years, 0.150; 25-
35 years, 0.282; >35 years, 0.400).  Assuming the cumulative enrollment distribution of the 300 clients 
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apply to these 164 additional clients, the age-group-adjusted number (%) of clients estimated to have 
enrolled in care at any facility in Swaziland is 464 (41.9%) overall, and 155 ( 14.0%), 192 (17.3%), 269 
(24.3%), 342 (30.9%), and 409 (37.0%) within 3, 6, 12, 18, and 24 months of diagnosis, respectively.   
 
Facility Visitation without Enrollment in HIV Care 
Of the 1,105 clients, study personnel verified that an additional 49 (4.4%) clients had visited an HIV care 
facility but either (1) did not have their ART eligibility assessed through WHO clinical staging or CD4 test 
(n=37), or (2) had a CD4 test (without WHO clinical staging) but did not return to the clinic at least once 
after their CD4 test (n=12).  Of these 49 non-enrollment visitors (13 SHIMS females, 6 SHIMS males, 30 
SOKA males), the only documentation found at the facility for nine was the located white HTC form; the 
remaining 40 were documented either on a register or with a chronic care file.  These 40 clients visited 
the HIV care facility a median (Q1-Q3) of 1 day (0-43) after their HIV diagnosis, and had a median (Q1-
Q3) of 1 (1-1) visit to the facility.  Of the 30 SOKA clients who had visited a facility but had not enrolled in 
HIV care, 19 (63.3%) visited the facility only once on the day of their HIV diagnosis, and all had visited 
the facility within 30 days of their diagnosis.  Of the 12 clients who visited a facility and had a CD4 test, 
but did not return to the facility after their CD4 test [median CD4 count (Q1-Q3): 376 (256-524)], 6 
(50.0%) were eligible for ART.  Of the 49 clients who visited but did not enroll at the facility, 37 (75.5%) 
provided a telephone number and consented to be contacted in the future; study personnel found 
documentation that clinic staff had attempted to call two of the visitors.  
 
 
7.  Baseline Clinical Characteristics 
Study Groups Combined: Clinical Characteristics 
Table 7 includes findings on clinical and psychosocial characteristics at baseline among the 300 SHIMS 
and SOKA clients that study personnel verified had enrolled in HIV care.  Overall, the 300 clients enrolled 
in HIV care at a median (Q1-Q3) age of 32 years (26-38) and 285 days (43-566) after HIV diagnosis.  Of 
clients with documented baseline WHO clinical stage (n=279, 93.0%) or CD4-count (n=292, 97.3%); 
16.1% were classified at WHO stage III or IV; 64.3% had CD4 <350 cells/µl; and 66.0% were ART eligible 
by either clinical stage or CD4 count; 120 (40.0%) clients at baseline already had severe immunologic 
impairment (AIDS or CD4 < 200 cells/µl) (Table 7).  Although proportionally more clients in older age-
groups were ART eligible at baseline, half of clients <25 years were ART eligible (% ART eligible: <25 
years, 50.8%; 25-35 years, 67.4%; >35 years, 74.7%).    
 
Study Groups Combined: Psychosocial Assessments 
Of the 300 enrolled clients, assessments were documented (defined as either an observed check for 
“Yes” or “No”) for each of the following six psychosocial assessments included within the chronic care 
file: (1) disclosed HIV status to partner (n=158; 52.7%); (2) disclosed HIV status to family (n=166, 55.3%); 
(3) consented to be visited at home by Rural Health Motivator (n=139, 46.3%); (4) partner tested for HIV 
(n=140, 46.7%); (5) fears discrimination or violence (n=147, 49.0%); and (6) faces financial challenges 
(n=142, 47.3%).  Of the 300 enrolled clients, 108 (36.0%) had complete documentation for all six 
psychosocial assessments.  Of abstracted records, many indicated the client had disclosed their HIV 
status to a partner [40.7% of 300 (overall); 77.2% of 158 with complete documentation for this 
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assessment (documented)] or to family members (39.0% overall; 70.5% documented); that their partner 
had tested for HIV (30.3% overall; 65.0% documented); and that they could be visited by a Rural Health 
Motivator (31.3% overall, 67.6% documented).  Fewer chronic care files indicated the client was 
concerned about discrimination or violence because of their HIV status (12.0% overall; 24.5% 
documented) or faced financial hardships (12.3% overall, 26.1% documented).   
 
Study Group Differences 
As noted in Table 7, of the 300 enrolled clients, SOKA clients enrolled earlier in HIV care compared with 
SHIMS male and female clients: median (Q1-Q3) days from diagnosis to enrollment in HIV care: 119 (15-
566) vs. 313 (74-467) and 344 (71-622), respectively (Table 7).   Compared with male SHIMS and SOKA 
clients, SHIMS female clients were younger, proportionally more enrolled in care at WHO Stage I, and 
proportionally fewer were ART eligible at enrollment (Table 7).   
 
Table 7.  Client characteristics at enrollment in HIV care, by study-gender group. 
 
Characteristic 
SHIMS Females 
(n=136) 
SHIMS 
Males 
(n=73) 
Soka 
Uncobe 
(n=91) 
 
All Clients 
(n=300) 
Days from HIV diagnosis to enrollment, 
median (Q1-Q3) 
 344 (71-622) 313 (74-467) 119 (15-566) 285 (43-566) 
Years  of age, median (Q1-Q3) 28 (24-36) 35 (30-42) 32 (27-39) 32 (26-38) 
Psychosocial assessment      
     Disclosed status to partner 54 (39.7%) 38 (52.1%) 30 (33.0%) 122 (40.7%) 
     Disclosed status to family 54 (39.7%) 32 (43.8%) 31 (34.1%) 117 (39.0%) 
     Ok for RHM to make home visits 36 (26.5%) 24 (32.9%) 34 (37.4%)   94 (31.3%) 
     Partner tested for HIV 30 (22.1%) 32 (43.8%) 29 (31.9%)   91 (30.3%) 
     Fears discrimination or violence 16 (11.8%) 12 (16.4%)   8 (8.8%)   36 (12.0%) 
     Faces financial challenges 23 (16.9%)   9 (12.3%)   5 (5.5%)   37 (12.3%) 
     
WHO clinical stage documented  124 (91.2%) 69 (94.5%)   86 (94.5%) 279 (93.0%) 
WHO clinical stage3     
     I 88 (71.0%) 32 (46.4%) 47 (54.7%) 167 (59.9%) 
     II 23 (18.6%) 19 (27.5%) 25 (29.1%)   67 (24.0%) 
     III 13 (10.5%) 15 (21.7%) 13 (15.1%)   41 (14.7%) 
     IV 0 (0.0%) 3 (4.4%) 1 (1.2%)  4 (1.4%) 
     
CD4 count documented             131 (96.3%) 72 (98.6%) 89 (97.8%)      292 (97.3%) 
     
CD4 count, median (Q1-Q3)  350 (186-597) 247 (115-344) 262 (186-347) 280 (165-420) 
CD4 count category1     
      < 50  3 (2.3%) 3 (4.2%) 2 (2.3%) 8 (2.7%) 
     50 – 200 33 (25.2%) 27 (37.5%) 28 (31.5%) 88 (30.1%) 
     201 – 350 30 (22.9%) 25 (34.7%) 37 (41.6%) 92 (31.5%) 
     351 – 500 27 (20.6%)   9 (12.5%) 15 (16.9%) 51 (17.5%) 
     > 500 38 (29.0%)   8 (11.1%) 7 (7.9%) 53 (18.2%) 
     
ART eligibile2  71 (52.2%) 58 (79.5%) 69 (75.8%) 198 (66.0%) 
     
AIDS5 or CD4 < 200 cells/µl 43 (31.6%) 40 (54.8%) 37 (40.7%) 120 (40.0%) 
1 Percentages based on the number of clients that had documentation of having received the service (clinical staging or CD4 test). 
2 WHO Clinical Stage III/IV or CD4 < 350 cells/µl. 
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8.  ART Initiation 
Eligibility, Timeliness, & Clinical Status 
Table 8 includes findings on client characteristics at ART initiation.  Of the 300 clients who enrolled in 
HIV care, 208 (69.3%) were initiated on ART, of whom 202 (97.1%) were ART eligible at the time of 
initiation by WHO clinical stage or CD4 count; 121 (58.2%) clients at initiation had severe immunologic 
impairment (AIDS or CD4 < 200 cells/µl).  The 208 clients were initiated on ART a median (Q1-Q3) of 342 
(87-629) days after HIV diagnosis and 15 (7-28) days of their most recent CD4 test.  Of clients with 
documented clinical stage (n=200, 96.2%), 56 (28.0%) initiated on ART had AIDS (stage III or IV) (Table 8).  
Of the 208 clients, 201 (96.6%) had a median (Q1-Q3) CD4 count at ART initiation, of 213 (123-282).  Of 
the six ineligible clients (by clinical stage and CD4 count) who were initiated on ART, the median (range) 
CD4 count of five clients was 355 (351-386); the remaining male client was initiated on ART at CD4 of 
514 cells/µl and at a WHO clinical stage of I (all documented TB screenings for this client were negative).    
  
Table 8.  Client characteristics at ART initiation, by study-gender group. 
 
Characteristic 
SHIMS Females 
(n=77) 
SHIMS 
Males 
(n=62) 
Soka 
Uncobe 
(n=69) 
 
All Clients1 
(n=208) 
Days from HIV diagnosis to ART initiation, 
median (Q1-Q3) 
 
379 (112-673) 
 
325 (105-602) 
 
323 (35-603) 
 
342 (87-629) 
     
WHO stage documented  74 (96.1%) 60 (96.8%) 66 (95.7%) 200 (96.2%) 
WHO stage2      
     I 34 (46.0%) 18 (30.0%) 23 (34.9%) 75 (37.5%) 
     II 23 (31.1%) 22 (36.7%) 24 (36.4%) 69 (34.5%) 
     III 17 (23.0%) 16 (26.7%) 15 (22.7%) 48 (24.0%) 
     IV 0 (0.0%) 4 (6.7%) 4 (6.1%) 8 (4.0%) 
     
CD4 count documented 75 (97.4%) 61 (98.4%) 68 (98.6%)      204 (98.1%) 
     
CD4 count, median (Q1-Q3)3 211 (126-279) 174 (103-282) 241 (138-292)  219 (124-284) 
     
Days from CD4 assessment to ART 
initiation, median (Q1-Q3) 
      16 (5-27)        14 (7-21)       15 (7-29)        15 (7-28) 
     
CD4 count category2,3     
      < 50           3 (4.0%) 2 (3.3%)  3 (4.4%) 8 (3.9%) 
     50 - 200 32 (42.7%) 31 (50.8%) 24 (35.3%) 87 (42.6%) 
     201 - 350 34 (45.3%) 24 (39.3%) 37 (54.4%) 95 (46.6%) 
     > 350 6 (8.0%) 4 (6.6%) 4 (5.9%)       14 (6.9%) 
     
ART eligibile4 75 (97.4%) 59 (95.2%) 68 (98.6%) 202 (97.1%) 
     
AIDS5 or CD4 < 200 cells/µl 45 (58.4%) 40 (64.5%) 36 (52.2%) 121 (58.2%) 
     
1 Of 300 study clients who enrolled in HIV care. 
2 Percentages based on the number of clients that had documentation of having received the service (clinical staging or CD4 test). 
3 Based on the most recent CD4 either before ART initiation (n=203) or <30 days after ART initiation (n=1).  
4 WHO Clinical Stage III/IV or CD4 < 350 cells/µl. 
5 WHO Clinical Stage III/IV. 
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CD4 Gain after ART Initiation 
Of the 201 clients initiated on ART on whom a CD4 count at initiation was documented, a CD4 count 
after ART initiation was documented on 113 (56.2%).  Of these clients, the median (Q1-Q3) interval in 
days from the most recent CD4 test preceding ART initiation to the most recent CD4 test after initiation 
was 449 (251-655).  The 113 clients had a median (Q1-Q3) CD4 count at ART initiation of 226 (126-289) 
and a CD4 count after ART initiation of 337 (247-522), representing a net CD4-cell-count gain of 132 (38-
246).   
 
Eligibility at Baseline 
Of the 198 clients who were eligible for ART at baseline (Table 8), 187 (94.4%) were initiated on ART at 
the enrollment facility.  Of the 11 ART-eligible clients at baseline who were not initiated on ART, the 
median (range) number of days from enrollment in care to last facility visit for nine clients was 0 (0-17) 
(6 defaulted and three transferred to another facility).  Of the remaining two baseline-eligible clients 
who were not initiated on ART, one defaulted from care after enrollment and returned to the facility 
one time only 788 days after enrollment.  The other client visited the facility on the day of diagnosis and 
had a baseline CD4 test (count=320 cells/µl), returned to the facility and enrolled in HIV care 
approximately two years later, and had a documented CD4 count of 494 cells/µl after enrolling in HIV 
care (two years after the first CD4 test).  
 
9.  Retention in HIV Care 
Eligibility 
Table 9 includes findings on pre-ART and ART retention, by incremental 6-month observation periods.  
Of the 300 clients who enrolled in HIV care, 12 had died (n=5, 1.7%) or had transferred out of care (n=7, 
3.7%) before the end of the first 6-month observation period.  Retention analyses were restricted to the 
remaining 288 clients.  Of these, 98 pre-ART and 172 ART clients were eligible for the first 6-month 
retention analysis after enrollment (pre-ART retention) or ART initiation (ART retention).  Of the 98 pre-
ART clients, 19 were also included in the 6-month ART retention analysis because they remained in care, 
were eventually initiated on ART, and were eligible for the 6-month ART retention analysis (i.e., date of 
abstraction occurred >6 months after ART initiation).   Thus, 251 (270 - 19) unique clients were available 
for 6-month retention analyses for both pre-ART and ART care (Table 9).  Fewer clients were eligible for 
retention analyses for longer observation periods; for retention at 24 months, only 37 and 74 clients 
were available for pre-ART and ART retention analyses, respectively (Table 9). 
 
Pre-ART & ART Retention 
Retention in pre-ART care was low at 6-months (63.3%) and decreased considerably over time; at 24 
months after enrollment, 13 (35.1%) of 37 eligible clients were retained in pre-ART care (Table 9).  
Potential psychosocial predictors of defaulting from pre-ART care (e.g., non-disclosure to family 
members and partners, concerns of stigmatization or violence, financial hardship) could not be reported 
because these measures were completed on approximately half of enrolled clients.  Retention in ART 
care was high, and compared with pre-ART retention, higher for each observation period.  Retention in 
ART care was 92.4% 6 months after ART initiation, decreasing to 86.5% 24 months after ART initiation 
(Table 9).  Pre-ART and ART retention at 6 months did not vary substantially by study or age group; sub-
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group retention analyses beyond 6 months were not conducted because too few clients were available 
for these analyses.  
 
Table 9.  Retention in pre-ART and ART care, and HIV care (combined), by observation period and study-
gender group.1 
Patient Characteristic 
Pre-ART Care 
 
ART Care 
 
HIV Care 
Eligible2 
n 
Retained 
n   (%) 
 Eligible 
n 
Retained 
n   (%) 
 Eligible3 
n  
Retained 
n     (%) 
Observation period4         
       6 Months  98 62 (63.3)  172 159 (92.4)  251 202 (80.5) 
     12 Months  73 40 (54.8)  135 123 (91.1)  197 152 (77.2) 
     18 Months 52 23 (44.2)  103   91 (88.4)  150 109 (72.7) 
     24 Months 37 13 (35.1)    74   64 (86.5)  107   73 (68.2) 
         
                                               6 Month Retention 
Study-gender group         
    SHIMS Females 56 38 (67.9)    62   57 (91.9)  111   88 (79.3) 
    SHIMS Males 13   8 (61.5)    52   48 (92.3)    62   53 (85.5) 
    Soka Uncobe Males 29 16 (55.2)    58   54 (93.1)    78   61 (78.2) 
         
                                               6 Month Retention 
Age group         
≤ 30 years 59 38 (64.4)    78   73 (93.6)  128 102 (79.7) 
> 31 years 39 24 (61.5)    94   86 (91.5)  123 100 (81.3) 
1 Sixteen clients who transferred out of care or died were excluded from analyses. 
2 Includes 19 ART clients who were in pre-ART care for at least 6 months.  All 19 ART clients were defined as retained in pre-ART care; 19 retained 
at 6 months, 11 retained at 12 months; 5 retained at 18 months, and 4 retained at 24 months. 
3 The 19 ART clients who were also retained in pre-ART care are counted only once. 
4 For pre-ART clients, the observation period began on the date of enrollment and ended on the date at the end of the defined period (e.g., 6 
months after enrollment).  For ART clients, the observation period began on the date of ART initiation and ended on the date at the end of the 
defined period.  To be eligible, the date of abstraction had to occur after the date the observation period ended for each client. 
 
 
10.  Screening for Tuberculosis and Prescription of Cotrimoxazole 
Analytic Restriction   
Of the 288 clients eligible for retention analyses, study personnel located and used the chronic care file 
for data abstraction on 258 (90.0%).  Analyses were restricted to these 258 clients because 
documentation of TB screening and cotrimoxazole (CTX) prescription was incomplete on a per-visit basis 
for register and electronic medical record data abstractions.  Of these 258 clients, study personnel 
abstracted TB screening and CTX prescription data from pre-ART and ART follow-up visit sections only of 
the client’s chronic care file.   
 
Receipt of Services 
The 258 clients had a median (Q1-Q3) of 9 (4-14) follow-up visits to the facility after enrollment in care.  
During these follow-up visits, clients received a median (Q1-Q3) of 7 (2-12) TB screenings and 8 (3-13) 
prescriptions for CTX.  Of the 258 clients, 244 (94.6%) had at least one follow-up visit to the facility, of 
whom 226 (92.6%) were ever screened for TB and 239 (98.0%) were ever prescribed CTX.  Of 226 clients 
screened for TB, 40 (17.7%) screened positive at least one time and were considered suspect for TB. 
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11.  Primary Data Source Availability  
Enrollment & Non-enrollment Facilities 
Table 10 includes findings on the availability of primary data sources used to identify clients who 
enrolled in HIV care at the 92 visited facilities.  Findings are reported of facilities in which >1 clients were 
verified to have enrolled in care (enrollment facilities; n=78) and facilities in which no clients were 
verified to have enrolled in HIV care (non-enrollment facilities; n=14) (Appendix I).  Primary data sources 
include the set of data sources that study personnel were required to use in accordance with standard 
procedures to identify enrolled clients.   
 
All Facilities Combined 
Of the 92 facilities visited, study personnel found that most had pink and white copies of HTC forms 
stored in binders or envelopes, and that most had expert clients available for interviews and chronic 
care files that could feasibly be searched (Table 10).  Nearly a third of the 92 facilities had an electronic 
medical record (EMR) system that could be searched for combinations of first and last name, and date of 
birth.  Of 108 total register months available (36 months for each of the three primary registers), the 
median (Q1-Q3) number of months that appointment, pre-ART, and ART registers were available to 
search for clients for calendar years 2011, 2012, and 2013 was 92 (72-103).  For all facilities, the median 
number of register months available was greater for pre-ART and ART registers than appointment 
registers (Table 10).  Of the 92 facilities, 13 (14.1%) had a data-source-availability rating of 1, defined as 
having a working EMR, at least one expert client available for interview, and 108 register months 
available for searching for the three primary registers combined; one (1.1%) facility had a rating of 4 in 
which none of these data sources were available (Table 10). 
 
Differences between Enrollment and Non-enrollment Facilities 
Compared with enrollment facilities, proportionally fewer non-enrollment facilities had HTC copies, 
EMR, expert clients, and chronic care files available to help search for and identify clients who enrolled 
in HIV care.  Non-enrollment facilities also had a lower median (Q1-Q3) of primary register months 
available for all three registers combined, and for appointment and pre-ART registers separately.   
Finally, proportionally more non-enrollment than enrollment facilities had data-source-availability 
ratings of 3 or 4 (lower availability); no non-enrollment facilities had a data-source-availability rating of 1 
(compared with 16.7% of enrollment facilities) (Table 10).  
 
Table 10.  Primary data sources available at enrollment and non-enrollment facilities. 
 
 
Primary Data Source1 
Enrollment 
Facilities2 
(N = 78) 
Non-enrollment 
Facilities3 
(N=14) 
 
All Facilities 
(N = 92) 
HTC  binders or folders    
     Facility copy (pink) 60 (76.9%) 10 (71.4%) 70 (76.1%) 
     Client copy (white) 48 (61.5%)   7 (50.0%) 55 (59.8%) 
    
Electronic medical records 26 (33.3%)   2 (14.3%) 28 (30.4%) 
    
Expert client(s) 64 (82.1%)   8 (57.1%) 72 (78.3%) 
    
Searchable chronic care files4  73 (93.6%) 12 (85.7%) 85 (92.4%) 
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Primary Data Source1 
Enrollment 
Facilities2 
(N = 78) 
Non-enrollment 
Facilities3 
(N=14) 
 
All Facilities 
(N = 92) 
Register months available 2011-2013, median 
(Q1–Q3) 5 
 
 
 
     Appointment registers  32 (24-36) 28 (22-36) 29 (24-36) 
     Pre-ART registers  34 (29-36) 30 (28-36) 33 (29-36) 
     ART registers  32 (24-36) 33 (20-36) 32 (24-36) 
     All primary registers combined   92 (72-103)   89 (60-108)   92 (72-103) 
Data source availability rating6     
     1 13 (16.7%) 0 (0.0%) 13 (14.1%) 
     2 47 (60.3%)   7 (50.0%) 54 (58.7%) 
     3 18 (23.1%)   6 (42.9%)      24 (26.1%) 
     4 0 (0.0%) 1 (7.1%)  1 (1.1%) 
1 Sources of data that were expected to be located and reviewed to verify if a client enrolled in HIV care in accordance with protocol standard 
operating procedures. Note: secondary data sources (e.g., laboratory and attendance registers) were used when primary sources were not 
available.  
2 Facilities where >1 clients were verified as having enrolled in HIV care.  
3 Facilities where clients were referred or where clients self-reported having enrolled in care, but where no clients were verified as having 
enrolled in care.  
4 When feasible, abstraction teams searched through all of the chronic care files at a facility to verify enrollment in care of a client.  A targeted 
approach was used to search through client charts if the filing system at the facility allowed (e.g. files arranged alphabetically by client’s 
surname). 
5 Observed register months 2011-2013 with >1 documented client entries.  Some registers did not have any documented entries during particular 
months (e.g., pages missing, clinic not open, or registers were not used during that period).  Note: 36 months of register documentation is 
possible for each register; 108 (3*36) total months of register documentation is possible for all three registers combined.  
6 Rating 1: EMR and EC, and 108 register months available (36 months for each primary register); Rating 2: EMR and EC available but <36 register 
months available for each register, OR either EMR or EC available and at least 36 months available for one primary register with <36 months 
available for other two primary registers; Rating 3: EMR and EC available, and 0 months available for all primary registers, OR <36 months 
available for all three primary registers, EMR or EC available or not; Rating 4: Neither EMR and EC available, and 0 months of primary registers 
available.  
 
12. Quality Assurance  
Data Abstraction Form Reviews  
A total of 135 data abstraction forms (DAFs) were identified through manual and automated reviews of 
electronic records for having >1 missing or inconsistent data (e.g., clinical staging) (n=103), or comment 
information suggesting that the client might have received care at an alternate facility (n=32).  Of the 
103 DAFs with missing or inconsistent data, data issues were resolved for 71 (68.9%) either through a 
review of DAF and other client records (n=27) at the office, or by returning to the facility and validating 
the DAF against available data sources (n=44).  Data issues for the remaining 32 DAFs were unresolved 
because required information was missing or could not be located from one or more data sources at 
visited facilities.  Of the 32 DAFs suggesting that clients might have enrolled elsewhere for HIV care, 
study personnel visited each of these facilities and found 11 (34.4%) clients enrolled at these facilities.   
 
Data-abstraction Validation 
Of 78 enrollment facilities and 300 enrolled clients, abstraction-validation teams led by the ICAP deputy 
project coordinator and CDC technical advisors revisited 15 (19.2%) facilities and validated DAFs against 
data-abstraction sources for 120 (40.0%) enrolled clients.  High-volume facilities in each of the four 
regions were purposefully selected for data-abstraction validation, and DAFs for all clients who enrolled 
in care at the selected facilities were validated.  Of the 120 validated DAFs, one (0.8%) was incorrectly 
matched to another client and eight (6.7%) had important transcription or missing-data errors.  Missing 
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data errors on four of the eight DAFs were attributed to EMR abstractions (not to abstractor error); 
these four DAFs were re-abstracted with chronic care files which had not been previously located. 
 
Enrollment Validation 
At 12 of the 15 facilities visited, abstraction-validation teams also conducted an additional search for all 
clients who reported in Component II interviews that they had enrolled at that facility, but were not 
verified as having enrolled by study personnel in previous data-abstraction visits.  Of 34 clients who 
reported attending these facilities, data sources for two (5.9%) were located, matched to the clients, 
and abstracted.  Finally, at the approximate mid-point and at the end of the study, abstraction-
validation teams re-visited 28 referral facilities (including 14 of the 15 validations facilities) and 
attempted to locate records on 328 clients who had not been previously matched with facility records.  
Depending on the facility visited, these clients represented either all or a sample of clients who had not 
been previously matched with records at that facility.  Of these 328 clients, data sources for 13 (3.9%) 
were located, matched to the client, and abstracted.  
 
Data-entry Validation 
An approximate 10% sample of DAFs of clients who enrolled in HIV care, and a 10% sample of defaulter 
tracing (DTF) and clinic characteristics (CCFs) forms (n=161 forms total) were randomly chosen for data-
entry validation.  The validation was conducted by the CDC project manager who compared each 
variable value recorded on the 161 forms against its corresponding value in the electronic record.    All 
161 forms had a corresponding record in the electronic database; no major data-entry errors were 
identified.  Minor data-entry errors were identified and corrected for seven DAFs and one DTF.   Of the 
seven DAF data-entry errors, all involved the open-ended comment field and were thus classified as 
minor.  The one data-entry error on the DTF was an incorrect date entered into the interviewer call log.   
 
 
Discussion 
 
Principal Findings 
Enrollment in HIV Care 
In this first study of its kind in Swaziland, the retrospective linkages evaluation (Project RetroLink) found 
that of over one thousand clients newly HIV diagnosed in community and male-circumcision clinic 
settings throughout Swaziland in 2011 and 2012, less than one in ten (9.1%) were verified to have 
enrolled in HIV care within three months of their HIV diagnosis and less than one in four (24.1%) were 
verified to have enrolled in care within two years of their diagnosis.  Even after adjusting for non-
response, unacceptably few clients (37.0%) enrolled in HIV care within two years of their diagnosis.  
Similar very low rates of verified enrollment in HIV care were observed for both men and women 
diagnosed in their homes, among men seeking MC services, in each of the four regions of Swaziland, and 
in all age groups.  Although older persons in our sample were more likely to have enrolled in HIV care at 
each observed time period after diagnosis, less than one in three (31.4%) in the oldest age group (>35 
years) were verified as having enrolled in care within two years of diagnosis.         
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Clinical Status and Retention in Pre-ART Care 
Of the few RetroLink clients who were verified as having enrolled in HIV care, two-thirds were already 
eligible for ART, and four in ten had severe immunologic impairment at the time of enrollment.  Of 
clients who were initiated on ART, nearly half were initiated 1 or more years after their HIV diagnosis.  
Although we found that a large majority of clients who were initiated on ART were retained in HIV care 
24 months after initiation, of the clients verified to have enrolled in pre-ART care, nearly half defaulted 
from care within 12 months of enrollment.  Consistent with those of the Swaziland National ART 
Program Evaluation, our findings suggest that many persons who are initiated on ART in Swaziland are 
initiated late in the course of their HIV disease, and thus considerable HIV transmission might be averted 
by reducing delay in ART initiation.5-9,11  
   
Main Conclusions 
Presuming that a large majority of all HIV-diagnosed clients eventually enroll in HIV care, our findings 
suggest that many Swazis newly HIV diagnosed in 2011 and 2012 may delay their enrollment in HIV care 
for years.  Moreover, among the few newly diagnosed clients who enroll early in pre-ART care, many 
default from care after only 1 year.  Given the established efficacy of ART in preventing HIV transmission 
to sexual partners, our findings suggest that the high HIV incidence observed in Swaziland may be 
attributed, at least in part, to the long delay in ART initiation among clients after their HIV diagnosis 
either from (1) not enrolling in HIV care soon after diagnosis, or (2) defaulting from pre-ART care among 
the few who enroll early.  National procedures designed to help facilitate enrollment in HIV care or 
retain clients in pre-ART care either were not sufficiently applied and documented at this time, or if 
applied in accordance with the SOP, did not apparently work for most clients in our study.  The failure in 
either application or efficacy of these linkage procedures was particularly acute for clients under 25 
years of age, less than one in five (18.8%) of whom were verified to have enrolled in care within two 
years of their diagnosis. 
 
Linkage Services 
Missed Opportunities to Provide Linkage Services 
Notably, we found that there was considerable opportunity to intervene and help clients enroll early in 
HIV care: nearly three in four (71.4%) of the 1,105 clients provided a telephone number and consented 
to follow-up contact at the time of their diagnosis.  Consent for follow-up contact was similar among 
men and women, and of clients and who missed their enrollment appointment at referral facilities.  
RetroLink staff were able to call and interview many of these clients >900 days after providing their 
telephone number at HIV diagnosis.  Of those contacted, nearly nine in ten agreed to discuss with 
persons whom they didn’t know sensitive topics on HIV/AIDS, including whether they had enrolled in 
HIV care, and reasons for not enrolling in care.  Of clients who reported never enrolling in HIV care, two-
thirds reported wanting to enroll and accepted a new appointment and referral to an HIV care facility.  
Although fewer younger than older clients were reached, relatively few contacted clients refused to be 
interviewed, suggesting that had the calls been conducted soon after diagnosis (e.g., 1 week after 
defaulting from the enrollment appointment), linkage services could have been provided to most clients 
in accordance with the National SOP.   
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Delivery and Storage of HTC Referral Forms 
The HTC referral form delivery system is essential to providing linkage services because it is the only 
means available for facility staff to appoint clients, and to initiate reminder and missed-appointment 
calls.  We found that in many facilities, particularly those that are government operated, pink referral 
forms were most often maintained in accordance with the National SOP in either the expected or 
arrived patient binders that staff easily accessed.  Although rare, at some facilities, forms were not 
maintained at all or were maintained in envelopes that were not readily accessible, and most likely, 
never used.    
 
Although managed well at most facilities, we found pink HTC forms for only half of the clients at facilities 
to which they were referred.  Although it is unknown what percentage of forms were actually delivered 
and available for use for linkage services at the time of the enrollment appointment, these findings 
suggest that many forms may not have been delivered.  We also learned at several facilities that the 
referral forms often arrived >2 weeks after HIV diagnosis and could not be used to appoint and remind 
clients of their upcoming enrollment appointment (but apparently still could have been used to make 
calls to appointment defaulters).  Of clients who enrolled in HIV care, we found white copies of their 
HTC referral forms on less than one in five.  It is unknown whether the low percentage of located white 
referral forms was attributed to storage practices at facilities (sometimes white forms were found in the 
chronic care file rather than the arrived patient binder) or to clients failing to bring their referral form.  
Given the observed management of forms at most facilities, however, it is likely that most of these 
clients simply didn’t bring their forms.   
  
Reminder and Appointment Defaulter Calls 
Despite the availability of many HTC forms which facility staff could have used to SMS text or call clients 
to remind them of their appointment or missed appointment, documentation of these calls were found 
for very few clients.  Notably, nearly all clients were referred to facilities that had received training to 
implement the national linkage and retention SOP as evidenced by the appropriate storage of HTC 
forms, that had cell phones and airtime credit to make these calls, and that had linkage focal persons 
and specific nurses or expert client counselors charged with making calls.  We also found that call logs 
were often used at many facilities, but these were used for clients who had enrolled in care, rather than 
for clients who were supposed to enroll in care.  Although we cannot rule out that SMS texts or calls 
were made in accordance with the National SOP, but simply not documented, we believe clients were 
not called for two main reasons.   
 
First, only approximately one in ten referred clients were found to be recorded in appointment registers 
maintained at referral facilities.  In accordance with the National SOP, the appointment register is used 
to monitor when clients should be sent SMS appointment-reminder texts or when calls should be made 
to address missed appointments.  Because very few clients were appointed in the register, the regular 
means by which clinic staff manage calls for clients in care was not implemented for clients referred to 
HIV care.  At nearly all referral facilities, we did not find other mechanisms by which staff managed SMS 
texts and calls to clients referred to care (e.g., documentation of calls on referral forms maintained in 
expected patient binders).   
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Second, very few clients interviewed as part of Component II who had defaulted from their enrollment 
appointment remembered ever receiving an SMS text reminder or telephone call from the facility.  
These clients should have received at least one SMS text before their scheduled appointment and at 
least one call after their missed appointment.  Although failure to recall these SMS texts or calls is 
certainly possible, we were encouraged that many interviewed clients remembered the specific facility 
to which they were referred at the time of their diagnosis.  If they remembered the specific referral 
facility, it is reasonable that at least some would have remembered receiving one of the two expected 
contacts from that facility.   Because of the consistency of findings from both facility and client 
perspectives, we conclude that very few of the 1,105 referred newly HIV diagnosed clients ever received 
an SMS text or telephone call from the facility either before their enrollment appointment or after they 
missed their enrollment appointment. 
 
Linkage Services for Soka Uncobe Clients 
Although few newly HIV diagnosed SOKA clients received linkage services from referral facilities, many 
received linkage services at the point of HIV diagnosis.  It was standard practice at many of the 
Population Services International (PSI) supported Soka Uncobe sites that clients were offered the 
opportunity to meet with expert client counselors after being informed of their HIV diagnosis.  Expert 
client counselors are HIV-positive clients who are successfully adhering to ART and managing their HIV 
disease; who are open about and living positively with HIV; and who have received specialized training 
to help new clients understand the nature and value of HIV care, and to provide psychosocial support to 
help clients remain in HIV care. 
 
As part of linkage services, expert client counselors provided some informational and psychosocial 
counseling, used a standard form to assess and attempt to resolve barriers to HIV care (readiness 
assessment form), and when appropriate, escorted some clients to HIV care facilities at co-located sites.  
During HTC form reviews conducted at the 13 SOKA sites to identify eligible clients for RetroLink, we 
found that many medical circumcision files of HIV-positive clients included completed readiness-
assessment forms.   Anecdotal reports from some expert client counselors during Soka Uncobe suggest 
that the readiness-assessment forms were helpful in identifying potential barriers to care and guiding 
discussion on HIV/AIDS and HIV care (Appendix B).   
 
Differences in Early Enrollment in HIV Care 
Interestingly, although similar enrollment rates were observed between study-gender groups overall 
and within 18 months of diagnosis, proportionally more SOKA than SHIMS clients enrolled in HIV care 
within 3-6 months of diagnosis.  Although many reasons might explain this difference, observed 
differences in early enrollment in care might be attributed to (1) that many Soka sites were co-located at 
HIV care facilities, and enrollment in care might have been more convenient at these potentially better-
known facilities; (2) that young men seeking circumcision services (health seekers) may have a greater 
propensity for health care than their general-population peers who accepted, but did not seek HTC 
services at home; and (3) that many SOKA clients received at least some linkage services from expert 
client counselors, including escort services at co-located facilities.  It is unknown whether expert client 
counselors charged with follow-up responsibilities would have been able to take advantage of the initial 
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relationship established from their single HIV post-test encounter and help more SOKA clients enroll and 
remain in care.  As noted below, however, brief case management services (i.e., 1-5 encounters 
following diagnosis) is one of the few evidence-based linkage interventions known to increase early 
enrollment in HIV care. 
 
Reasons for not Enrolling in HIV Care  
As reported in many studies, the most frequently reported reasons for not enrolling in HIV care among 
clients interviewed during Component II included feeling well and not perceiving the need to receive 
care; inconvenience (not having the time for HIV care, and perceptions of long wait times to see a 
provider); and costs (perceptions of expenses for transport and potentially opportunity costs from lost 
work).23,24  A minority of clients who did not enroll in HIV care reported that they had not enrolled 
because of perceived low quality or efficacy of care, or that they were not infected with HIV (a few 
clients reported re-testing HIV negative).  These findings suggest linkage-intervention targets at social, 
facility, and individual levels.  For example, low perceived need to enroll in HIV care, and perceived costs 
and inconvenience are well recognized barriers to care that could be addressed through social 
marketing during community HTC outreach campaigns; decentralized HIV care, task shifting, and policies 
to reduce wait times at facilities; and follow-up counseling, escort, and treatment-navigation services 
provided by expert-client counselors.23-29  
 
The well-established importance of task shifting and decentralized HIV care is underscored in our 
findings of substantially greater enrollment at clinics than hospitals and health centers to which clients 
were referred; and in rural and peri-urban areas, at clinics served by dirt roads.26-29 For SHIMS clients 
diagnosed at their homes, these findings were not unexpected given substantially greater congestion 
and longer wait times we observed at large facilities, mostly served by paved roads at plausibly greater 
distances from client residences.  These associations were not observed for SOKA clients, who were 
more likely than SHIMS clients to be referred to larger urban facilities served by paved roads and often 
co-located at circumcision sites.  Notably, substantial scale up of decentralized HIV care to small rural 
clinics in Swaziland began at the time of SHIMS and Soka Uncobe.  Our findings suggest that for men 
diagnosed through home-based HTC, decentralized care at presumably more convenient clinics is 
particularly important. 
 
Enrolling in Alternative Facilities 
Interestingly, we found that over one quarter (28%) of clients who were verified to have enrolled in HIV 
care enrolled at facilities to which they were not referred (alternate facilities).  Of clients who enrolled at 
an alternate facility, most reported that they chose the facility for reasons of convenience (living closer 
to the facility and perceived shorter wait times); however, many also reported attending the alternate 
facility because they perceived care was better at that facility and that staff were more respectful to 
clients.  Assuming that most clients did not change their residence from the time of diagnosis to 
enrollment in care, these findings suggest that counselors should ensure that the most convenient 
facilities are discussed as potential referral facilities.  However, these findings also underscore the 
importance for counselors to explore perceived barriers to care at nearby facilities and ensure that 
concerns about the quality of care and the treatment of clients are explored and addressed.  Notably, at 
51 
 
the point of diagnosis, counselors can assess these perceptions and help clients resolve potential 
barriers to care—but an intervention based on a single encounter with clients who have just been 
informed of their HIV diagnosis and who haven’t fully realized the implications of the diagnosis on 
enrollment in care, should not be expected to have considerable impact on early enrollment and 
retention in care.  
 
Health Visitation without Enrollment in HIV Care 
We found that some clients visited HIV care facilities only once or twice and did not meet our definition 
of enrollment in care.  This was particularly true of SOKA clients, of whom nearly one in ten had visited 
the facility on or shortly after the day of their HIV diagnosis, but apparently never returned to that 
facility.  These clients were not classified as having enrolled in care because they did not undergo clinical 
evaluation (WHO staging), and if tested for CD4, were not informed of their CD4 test results.  
Unfortunately, half of the facility visitors who were CD4 tested were eligible for but not initiated on ART.   
 
The high rate of facility visitation without enrollment is discouraging, because these clients were 
“linked” to HIV care.  Information on the individual circumstances of these clients and the context of 
their facility visits was not available to RetroLink staff.  It may be true that some of these clients (the 
majority of whom were SOKA) were simply escorted to the facility in accordance with standard 
procedures but were not provided services because of the time of their visit or were not ready to enter 
HIV care at that time.  Most (75%) of these clients provided a telephone number and consented to be 
contacted; if counselors at HIV diagnosis were responsible for following up on clients, it is possible that 
they might have identified and resolved apparent barriers to care or facilitated enrollment at a more 
suitable facility.   
 
HIV Care 
TB Screening, CTX Prescription, & ART Initiation & Retention 
RetroLink staff found that a large majority of clients who enrolled in HIV care received timely services in 
accordance with national treatment recommendations.  Based on documentation of follow-up visits in 
chronic care files, nearly all study clients were prescribed cotrimoxazole and screened for symptoms of 
tuberculosis, and nearly all received these services at every follow-up visit.  Encouragingly, nearly all 
clients eligible for ART at baseline were initiated on ART, and three-quarters of ART clients were initiated 
within 30 days of their most recent CD4 test.  Consistent with findings from the National ART Program 
Evaluation, nearly nine in ten ART clients were retained in ART care two years after initiation.11 The few 
clients who were eligible at baseline and did not receive ART either defaulted or transferred from care 
the day of or soon after ART eligibility was determined.  Of the few clients initiated on ART who were 
ineligible by CD4 count and clinical staging, all but one had CD4 counts slightly above the 350 cell-count 
treatment cutoff.   Consistent with findings from the National ART Program Evaluation, of study clients 
who were initiated on ART and who had a follow-up CD4 test, over half had a net median CD4-cell count 
gain of over100 cells/µl.11   
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Trends in CD4 and WHO Clinical Staging at ART Initiation 
Encouragingly, RetroLink findings suggest that trends of increasing CD4 count and decreasing WHO 
clinical stage III/IV at ART initiation observed in the national ART program evaluation (2004-2010) may 
be continuing beyond 2010.11  In the national ART program evaluation, the median (Q1-Q3) CD4 count at 
ART initiation increased from 94 (35-151) in 2004/2005 to 180 (98-275) in 2010.  In RetroLink, the 
median (Q1-Q3) CD4 count at ART initiation was 219 (124-284).  In the national ART program evaluation, 
the percentage of clients on whom ART was initiated at WHO clinical stage III/IV, decreased from 
approximately 90% for both men and women in 2004/2005 to 40% of women and 53% of men in 2010.11 
In RetroLink, the percentage of clients on whom ART was initiated at WHO clinical stage III/IV was 23% 
for women and 30% for men.   
 
Psychosocial Assessment & Intervention 
Unfortunately, psychosocial assessments were not documented in chronic care charts for half or fewer 
of enrolled clients, and just over one-third had complete documentation on the set of six assessments 
we chose to evaluate.  The six psychosocial assessments were selected for abstraction because of their 
importance to retention in care and providing HTC to persons at high risk for undiagnosed infection.  As 
a result of incomplete documentation, it is unclear whether a majority or minority of enrolled clients 
had disclosed their status to partners and family members, whether their partners had tested for HIV, or 
whether clients agreed to home visits by a rural health motivator.  Although documentation was 
incomplete, an important minority of clients who enrolled in care indicated that they feared 
stigmatization or violence due to HIV/AIDS or faced financial hardships.   
 
Limitations 
1. Estimation of Enrollment in Care 
RetroLink findings are subject to four important limitations.  First, our reported adjusted estimate of 
enrollment in HIV care should be considered a minimum estimate because of the limited availability of 
data sources at some facilities and because of human error in searching for matching names in source 
documents at HIV care facilities.  Although we were encouraged to find that most data sources were 
available at many facilities, including chronic care files, expert client counselors, and appointment, pre-
ART, and ART registers dating back to 2011, some facilities had fewer sources to identify enrolled clients.  
Notably, none of the facilities at which study personnel were unsuccessful in locating clients (non-
enrollment facilities) received a data-source-availability rating of 1 (complete availability); and compared 
with enrollment facilities, fewer non-enrollment facilities had available data sources of each type.  
Although unknown, it is reasonable to expect that at least some clients enrolled at facilities and study 
personnel were simply unable to verify their enrollment because of the lack of available data sources.  
 
Despite the challenges of searching for enrolled clients at facilities (often requiring comprehensive page-
by-page reviews of 3 different types of registers over 108 months of documentation), we were 
encouraged by the outcomes of quality assurance audits headed by the ICAP deputy coordinator and 
CDC technical advisors.  Audits on 364 clients, who were not initially verified as having enrolled in care, 
identified only 15 additional enrollments.  We were also encouraged that of 267 Component II 
interviews, only 13 clients who were originally missed at referral facilities in Component I were found 
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after a second or third attempt in Component II (2 of the 13 clients were found through quality 
assurance audits).  These modest gains in verified enrollments from quality assurance audits and 
Component II interviews suggest that standard operating procedures implemented at facilities, and the 
use of all available data sources including a mandatory three-register review by teams of two, were 
reasonably effective.  Despite our efforts, however, undoubtedly a few enrolled clients were missed, 
and thus the adjusted enrollment rates should be considered minimum estimates.   
 
2. Validity of HIV Care Data 
RetroLink findings on clients who enrolled in HIV care are also subject to errors and omissions of clinical 
information recorded on facility registers and chronic care files, and entered into electronic medical 
records.  With respect to data errors, with the exclusion of some CD4 test results, it is unknown the 
extent to which recorded information reflected actual clinical practices and client conditions.  RetroLink 
was not designed, for example, to verify that clients received documented screenings for tuberculosis 
and prescriptions of cotrimoxazole, and whether recorded WHO clinical stages were accurate.  To the 
extent possible, however, study personnel abstracted CD4 test results directly from available laboratory 
slips (e.g., FACSCount sample reports) rather than from results recorded in data sources.  Laboratory 
CD4 result slips were not available for EMR and register data abstractions, and not all CD4 result slips 
were maintained in chronic care files.  Although not quantifiable, study personnel did observe high 
consistency between CD4 results on laboratory slips and values recorded in chronic care files.   
 
With respect to omissions, we learned that at several facilities some client visits and client services are 
not routinely documented on chronic care files.  For example, per standard procedures at some 
facilities, new clients on their first visit provide blood specimens for baseline tests are not seen by a 
clinician and do not have chronic care files created or “opened.”  At these facilities, chronic care files are 
opened after the client returns to receive their test results and are examined by a provider (thus the 
date of the baseline CD4 test recorded in the file precedes the date of the first recorded clinic visit).   We 
also learned that some clients who are ART eligible at baseline may revisit the clinic more than once for 
required ART readiness counseling, and that these clinic visits may either precede opening the chronic 
care file or are not documented on the chronic care file (personal communication, Dr. Sikhathele 
Mazibuko, August 5, 2014).  Thus, as documented in their chronic care file for some clients, ART appears 
to be initiated on their very first clinic visit when in reality, several visits have preceded ART initiation.  
Because early visits are not documented for all clients, we did not report the median (Q1-Q3) interval in 
days from the first clinic visit to ART initiation, and we also do not report the median (Q1-Q3) number of 
total clinic visits (only follow-up pre-ART and ART visits are reported).  Finally, reported time intervals 
may not be precise because of undocumented visits and errors in reported dates of visits (we found 
some unresolved inconsistent chronologies).     
 
3. Fidelity of Data Abstraction 
Findings from this study are also subject to omissions and errors in correctly matching clients with 
facility data sources, transcribing clinical data onto data abstraction forms, and entering data from forms 
into electronic databases.  To mitigate these potential errors, we required team leaders to review, and 
to the extent possible, verify in the field all completed data abstraction forms.  At the ICAP office, we 
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also established a two-level review of submitted forms for completeness, legibility, and consistency, and 
all forms were double-data entered.  We also reviewed manually and through automated checks all 
entered electronic records for incomplete and inconsistent data, and returned data abstraction forms to 
facilities to try to complete omitted data or resolve noted inconsistencies.  To ensure data were 
accurately transcribed, we validated 40% of data abstraction forms completed on enrolled clients by 
comparing all recorded data against the corresponding data source.  In these audits we found very few 
records with notable errors; only one record was found in which the data were abstracted on an 
incorrect client (matching error).  Finally, our 10% validation of all variable fields against values recorded 
on paper records yielded no notable data-entry errors.   Although our audits were extensive, we could 
not validate all forms and undoubtedly a few data-abstraction errors exist.  
 
4. External Validity & Currency 
Finally, RetroLink findings are limited to SHIMS and SOKA clients diagnosed through home-based HTC 
and provider-initiated HTC at SOKA sites in Swaziland in 2011 and 2012.  Although this project is one of 
the largest of its kind with a sample size of over one thousand newly HIV diagnosed persons, it is 
unknown the extent to which observed early enrollment and retention in care outcomes are applicable 
to other populations in Swaziland, such as clients tested in other clinical settings or clients tested at 
stand-alone HTC sites.  RetroLink is also limited to describing linkage services provided at HIV care 
facilities in 2011/2012, and early enrollment and retention outcomes of the 2011/2012 cohorts.  Thus, 
our findings may not reflect current linkage-service practices in HIV care facilities or by HTC providers, 
and early enrollment and retention outcomes among cohorts of clients HIV diagnosed in 2013/2014.  
Population Services International, for example, currently provides ongoing telephone follow-up of all 
clients who they newly HIV diagnose through their New Start HTC site, and through community-based 
HTC.  Indicators from their linkage program suggest that as many as 64% of clients might enroll in HIV 
care.30   Interestingly, if found to be true (64% reflects verified enrollment as defined in RetroLink), these 
findings are similar to verified enrollments among the very few clients who were called by facility staff 
(50%) in accordance with the National SOP, suggesting that follow-up interactions post-HIV diagnosis 
may help some clients enroll in care.  
 
Recommendations 
Given the importance of ART in reducing HIV-associated mortality and HIV transmission to offspring and 
partners, our findings call for urgent action to strengthen linkage and pre-ART retention services in 
Swaziland.  Five principal actions that might be taken to address these needs include: (1) holding one or 
more national meetings to re-focus providers on the importance of and exploring strategies to improve 
early enrollment and retention in HIV care; (2) assessing current linkage-service practices at HIV care 
facilities, and if needed, conducting refresher trainings to ensure compliance with the national linkage 
and retention SOP; (3) developing and implementing standard operating procedures and reporting tools 
for routine national reporting of linkage indicators; (4) implementing and evaluating evidence-based 
linkage interventions that are not currently implemented as part of the National SOP; and (5) 
establishing that HTC providers, rather than HIV-care providers, have the primary responsibility in 
delivering evidence-based linkage services and ensuring that newly HIV diagnosed clients enroll early in 
HIV care. 
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1. National Meetings on Linkage & Retention in HIV Care 
Convening one or more national meetings with public health authorities and stakeholders should be 
considered to take stock of RetroLink findings in the context of current linkage practices; current 
estimates and gaps of understanding enrollment in HIV care following diagnosis; gaps in service delivery 
and recommendations by international public health and research organizations; and potential new 
strategies to improve early enrollment and retention in care.  This meeting could serve to help populate 
and launch task forces to address one or more of the below recommendations or alternative consensus 
recommendations identified from the meetings.  
 
2. Assessing Current Practices & Retraining on National Linkage & Retention Procedures 
Evaluating whether current linkage and retention procedures are routinely conducted in accordance 
with the national linkage and retention SOP should be considered.  These evaluations could be 
conducted in a single day at selected HIV care facilities.  Audit teams, for example, could examine the 
management of referral forms in expected and arrive patient binders, whether newly referred clients 
are recorded in appointment registers, and whether telephone logs have documentation on SMS text or 
phone call reminders to referred clients.  Teams could evaluate the percentage of appointed clients who 
were called before or after their scheduled appointments and the percentage of referred clients who 
enrolled at the referral facility.  A sample of chronic care files could be selected on pre-ART clients and 
evaluated for adequate documentation of services and retention in HIV care.  If programmatic audits 
confirm inadequate compliance with the national linkage and retention SOP, refresher trainings of 
linkage and retention focal persons should be conducted as soon as possible.  If enough audits confirm 
RetroLink findings of low retention in pre-ART care, a national evaluation of pre-ART retention should 
also be considered.   
 
3. Developing, Implementing, & Reporting National Linkage Indicators 
To help monitor and improve delivery of linkage services over time, the development and routine 
reporting of national indicators of linkage to care should be considered.  These indicators should address 
the three dimensions of program evaluation including (1) key program processes, such as the number of 
referral forms received at facilities in the past month; (2) program outputs, such as the number of 
referred clients to whom automated SMS texts were sent or who were called by telephone before their 
enrollment appointment; and (3) program outcomes, such as the number of referred clients who 
enrolled in HIV care.  Definitions and methods for classifying clients who enroll in care should be 
carefully considered and made explicit in M&E standard operating procedures.  Notably, defining 
“linkage” as visiting the clinic one time or being “registered” may overestimate enrollment in HIV care 
because some clients do not return for a second visit; storing and counting client-delivered referral 
forms may considerably underestimate enrollment in HIV care because many clients do not bring their 
referral forms when enrolling in care.  Finally, because many clients enroll in HIV care at non-referral 
facilities, the responsibilities for reporting program outcomes should be vested with HTC providers who 
should be charged with follow-up responsibilities to trace and report whether their clients enrolled in 
HIV care.     
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4. Implementing & Evaluating Evidence-based Linkage Interventions 
To improve the potential impact of linkage services, the development, implementation, and evaluation 
of an expanded package of evidence-based linkage interventions should be considered.  Evidence-based 
linkage services that are currently recommended by WHO or the International Association of Physicians 
in AIDS Care (IAPAC), and that are not currently included in the National SOP include: (1) brief linkage 
case management for newly HIV diagnosed clients; (2) use of peer counselors and treatment navigators; 
and (3) point-of-diagnosis CD4 testing.24-29 Brief case management, demonstrated in a randomized 
controlled trial to increase early enrollment in HIV care, involves providing supplemental psychosocial 
support and strengths-based counseling over a limited number of face-to-face sessions to help clients 
cope with their new diagnosis and enroll in care.31,32 Peer counselors recommended by WHO are expert 
client counselors who can draw on their experiences of living positively with HIV and their specialized 
training to help clients understand the value and nature of HIV care.  Expert client counselors could 
escort and help clients navigate their enrollment in care at unfamiliar facilities, and with additional 
training, would seemingly be optimally suited to provide brief case management services.  Finally, 
provision of point-of-diagnosis and point-of-care CD4 has been shown to increase awareness of ART 
eligibility and increase the number of eligible clients on whom ART is initiated.33,34 Although each of the 
above recommended interventions are evidence based, their cultural and operational fit, feasibility and 
acceptance, and efficacy on early enrollment and retention in HIV care in Swaziland is unknown.  As part 
of any rollout of new linkage services, consideration should be given to appropriate evaluation of 
corresponding program processes, outputs, and outcomes.   
 
5.  Expansion of Linkage Responsibilities of HTC Providers 
Low compliance with the national linkage and retention SOP for SHIMS and SOKA clients in 2011 and 
2012, in retrospect, was not unexpected because of the reliance on (1) a specimen transport system to 
provide referral forms to facilities in a timely manner, and (2) on HIV clinic staff who through their 
training and orientation are unfamiliar with providing services to clients who are not under their care.  
Moreover, many newly HIV diagnosed clients enroll at facilities different from those to which they were 
referred.  The effect of linkage services provided by staff at a clinic to which clients may have chosen not 
to enroll is reasonably questionable.  For the above reasons and observed very low compliance with the 
National SOP, the implementation of new evidence-based linkage services should be the responsibility 
of HTC providers.  Responsibilities such as brief linkage case management provided by expert client 
counselors are a better fit with HTC providers who have established rapport with newly diagnosed 
clients and should be more aware than HIV care providers of the individual circumstances and needs of 
their clients, including barriers to enrollment in HIV care and potential strategies to overcome identified 
barriers.  
 
Closure 
RetroLink was a retrospective cohort study designed to evaluate early enrollment and retention in HIV 
care among clients newly HIV diagnosed at home and in male circumcision sites in Swaziland in 2011 and 
2012.  It is one of very few studies conducted of its kind and the first of its type in Swaziland.  Of over 
one thousand newly HIV diagnosed clients, we estimate that less than four in ten enrolled in HIV care 
within two years of their diagnosis.  Of the few clients who were found to enroll in pre-ART care, many 
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defaulted from care soon after their enrollment and nearly half defaulted and were lost to follow-up 
within 12 months of enrollment.  In spite of well-recognized limitations of retrospective evaluations, our 
findings are a call to action to improve linkage services and early enrollment and retention in HIV care in 
Swaziland.   
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 APPENDIX A:  HTC REFERRAL FORM 
 APPENDIX B: CARE READINESS ASSESSMENT FORM 
Assessments and Measures of Barriers to HIV Care      YES NO  
  
Open ended question EC poses to 
client 
Meaning inferred/ interpretation from the clients 
response 
YES 
(tick) 
NO 
(tick) 
1a. What do you believe about 
your HIV test result? (denial about 
HIV infection status)  
1b. Client believes he/she is not infected with HIV. 
 
  
2a. What do you believe about the 
effectiveness and side effects of 
HIV treatment?  
(beliefs about the efficacy and 
effects of ART) 
 
2b. Client believes HIV treatment is ineffective or 
harmful. 
 
  
3a. What do you believe will 
happen to your health if you don’t 
receive HIV care  
and treatment? (severity of 
HIV/AIDS without treatment) 
 
3b. Client believes that he/she will be healthy without 
receiving HIV care or treatment. 
 
  
4a. What do you believe about the 
need to go to the clinic ART unit 
even if you feel well? (low 
perceived need for HIV care) 
 
4b. Client does not believe he/she needs to go to the HIV 
clinic because of perceived good health or wellness. 
 
  
5a. What do you believe about the 
quality of care and how patients 
are treated at the clinic? (low 
quality of care) 
 
5b. Client believes he/she will be treated poorly or 
receive poor care at the Clinic .ART unit 
 
  
6a. What do you believe might 
happen if people that you know 
will see you at the clinic ART Unit? 
(stigmatization and discrimination)  
 
6b. Client is concerned or afraid about being identified as 
HIV+. 
 
  
7a. How will your spouse, family, 
and friends react if they found out 
you are going to the clinic ART 
Unit? (low support for care and Tx) 
v 
7b. Client believes he/she will not have support for HIV 
care from spouse,  family, or friends. 
 
  
8a. How will your community react 
if they found out you are going to 
the Clinic ART Unit? (low 
community support for care and 
Tx) 
8b. Client believes he/she will not have support for HIV 
care from their community. 
 
  
9a. What do you believe about the 
power of traditional healers or 
medicine to cure or control HIV 
(efficacy of traditional therapy) 
 
9b. Client believes that traditional healers or medicine 
are effective against HIV/AIDS. 
  
 10a. How much do you believe it 
will cost you for HIV care and 
treatment?  
 (costs for HIV care and treatment) 
 
10b. Client believes he/she cannot afford to pay for HIV 
care and treatment. 
 
  
11a. What other costs or 
responsibilities might prevent you 
from receiving  
care at the clinic AER Units? 
(transportation, work, family) 
 
11b. Client believes other costs or responsibilities (e.g., 
transportation, work, family) are barriers to care. 
 
  
12a. How would you feel if an 
RHM/HBC/ EC came to visit you at 
home if you missed your 
appointment? 
 
12b. Client is comfortable with RHM/HBC/ EC home visit 
and feel their visit would benefit them. 
 
  
 
11. What is the main barrier that might prevent you from making your appointment in two weeks at the clinic ART UNIT?  
[Note: if the barrier is above, circle M, for the main barrier; only one barrier may be noted as main.  If the barrier is 
not in the above table, write the barrier in the space provided below.] 
 
Other noted barriers to care at the clinic (Please tick)         YES NO 
 Do you currently have any other medical conditions ( e.g. ill health, disability)  
o Disability  (deaf/ dumb/ blind etc) 
o  Diabetes 
o TB 
o Mental illness   
 Do you sometimes go to bed hungry?      
 Drug use or abuse          
 Does your use of drugs/alcohol negatively affect your every day function?  
 Do you know how to read and write?      
 
[Note to the CLEC:] 
Where barriers have been identified, allow them to guide the counseling session. If the CLEC is unable to adequately 
address barriers, counsel the client, or feels that the barriers are beyond their capacity, it is advised that they seek the 
support of the Regional PSI APS officer or the SU Clinical teams. 
 
[Note: do not read the following sentence to the client; circle the appropriate response] 
12.  How confident are you that your client will make his/her appointment and receive care at the referred HIV clinic?   
a. Not at all confident.  [The client should be contacted again within 2 weeks.] 
b. Somewhat confident. 
c. Very confident
 APPENDIX C:  SOKA UNCOBE MALE CIRCUMCISION CLINICS 
Region MC Facility Name 
MC Clients  
Tested for HIV 
MC Clients 
 Tested HIV-positive 
Clients Eligible 
for Study 
Hhohho Family Life Association Clinic (Mbabane) 2,240 217 
Pigg's Peak Government Hospital 642 65 
Mkhuzweni Health Center 338 15 
Dvokolwako Health Center 213 11 
Sappi Health Center 250 10  
Ntfonjeni Clinic 69 6  
Malandzela Nazarene Clinic 57 2   
    
Lubombo Tabankulu Estates Clinic 374 75 
Siteki Public Health Unit 678 55 
RSSC Medical Services (Simunye/Lusoti) 315 33 
RSSC Medical Services (Mhlume) 134 18  
Siphofaneni Clinic 104 13  
Ubombo Sugar Hospital 121 11  
Mpolonjeni Clinic 57 6  
Sithobela Rural Health Center 184 5  
Ngomane Clinic 20 5   
    
Manzini PSI Manzini (Litsemba Letfu) 1,653 247 
Phocweni U.S.D.F Clinic 488 110 
Mankayane Government Hospital 932 61 
Family  Life Association Clinic (Manzini) 1,148 56 
Sigombeni Red Cross Clinic 118 7  
Mangcongco Clinic 32 3  
Bhekinkosi Nazarene Clinic 15 3  
Bulunga Nazarene Clinic 8 2  
Sibovu Clinic (Mahlangatsha) 165 1  
Luyengo Clinic 8 0   
    
Shiselweni Nhlangano Health Center 1,169 104 
JCI (Mphelandzaba) Clinic 645 36 
Matsanjeni Health Center 276 14  
Mtsambama Inkhundla 268 14  
    
Multiple 
Regions 
The Luke Commission  528 13   
  
 APPENDIX D:  DATA ABSTRACTION FORM 
GENERAL INSTRUCTIONS 
The Data Abstraction Form (DAF) is composed of 5 sections (A-E) that collect client-level information on demographic, behavioral, and clinical characteristics, and information on the 
processes and outcomes of the pilot linkage and retention SOP.  Each section should be completed in sequence; sections A and B will be completed at the ICAP central office, and 
sections C-E will be completed at those HIV care and treatment sites to which clients selected for this evaluation were referred.  Data abstractors must ensure that all sections of the 
DAF are completed in accordance with instructions, and that responses are clearly coded using ink (not pencil).  Any errors should be clearly marked through with an initialized and 
dated single line.  The below table provides information on the content, subjects, and locations of data abstraction for each section of the DAF.  Variable-specific instructions are also 
provided in the right-most column in each section of the DAF. 
      
Section Data Sources Data Abstraction Content, Subjects, and Locations 
A 
HTC Form 
Master list of facilities and 
codes 
Section A of the DAF collects client identifying and facility-referral information and will be completed on all subjects (clients) 
selected for the program evaluation.  Information collected in Section A will be used to identify/locate clients for data 
abstraction on subsequent sections of the DAF.  The HTC form and master list of facilities and codes will be used to complete 
all items in this section.  Section A will be completed at the ICAP central office after copies of all HTC forms of clients 
selected for the program evaluation are obtained. 
B 
EC Daily Register 
Linkage Register 
Section B collects information on linkage services that might have been provided as part of voluntary medical male 
circumcision (MC) services.  Section B will be completed only on MC clients selected for the program evaluation.  The EC 
daily register will be used to complete items B3-B5 and the Linkage Register will be used to complete items B6-B15.  Section 
B will also be completed at the ICAP central office after copies of all EC Daily and Linkage Registers are obtained.    
C 
Expected Patients Binder 
Arrived Patients Binder 
Appointment Register 
Call Register 
Pink HTC Referral Forms 
Section C collects information on linkage and retention SOP processes and linkage services provided at HIV care and 
treatment sites.  Five sources of data will be used in accordance with the variable-specific instructions noted in this section 
of the DAF.  Section C will be completed on all clients selected for the program evaluation at those care and treatment sites 
to which they were referred. 
D 
Pre-ART Register 
Chronic Care File 
ART Register 
Laboratory Register 
Section D collects information on whether clients selected for the program evaluation enrolled in HIV care and treatment.  
Up to four sources of information will be used to document enrollment in care in accordance with variable-specific 
instructions noted in this section of the DAF.  Section D will be completed on all clients selected for the program evaluation 
at those care and treatment sites to which they were referred. Section D is the last section of the DAF that is completed for 
clients who do not enroll in care.  
E 
Chronic Care File 
Pre-ART Register 
ART Register 
Laboratory Register 
Section E collects information on clinical services and outcomes of clients who enrolled in HIV care and treatment.  If 
located, the chronic care file should be the only source of data that is used to complete this section.  If the chronic care file is 
not located, the three registers may be used in accordance with variable-specific instructions noted on the DAF.  Section E 
will be completed on only those clients who are determined in Section D to have enrolled in care and treatment. 
 
  
  
  
A. Patient Identifiers 
Data Sources: HTC Form 
Master Facility List      
A1. Name of data abstractor  Capital letters only. 
A2. Date of data abstraction  D D M M Y Y Y Y  
A3. 
HTC form number (N) including 
initial letter (L) 
L N N N N N N 
The number is located in the upper right hand corner of 
form, include letter and all zeros. 
A4. 
Name and code of referring 
facility 
Name:                                                            Code: 
Under HTC Settings: record ‘Health Facility (name). Use 
master facility list to obtain code. 
A5. HTC setting SHIMS                   Soka Uncobe             
If form number is preceded with ‘A’, check SHIMS, if 
preceded with ‘B’, check Soka Uncobe. 
A6. Client first name  Capital letters only. 
A7. Client surname  Capital letters only. 
A8. Client code              Found below “Client first name.” 
A9. Date of birth D D M M Y Y Y Y  
A10. Physical address 
 
 
 
Capital letters only. 
A11. Region of residence  
Hhohho      Lubombo     Manzini     Shiselweni   
                                                                             
                                                                            Unknown  
Based on physical address. Check ‘Unknown’ if address 
is missing or unreadable. 
A12. 
Residence in urban, peri-urban, 
or rural area 
Urban        Peri-urban      Rural         Unknown  
Based on physical address. Check ‘Unknown’ if address 
is missing or unreadable. 
A13. Date of HIV diagnosis D D M M Y Y Y Y Under HTC Settings: record ‘Date of Visit.’ 
A14. 
Name and code of receiving 
facility 
Name:                                                            Code: 
Under “Referrals:” record “Name of health facility.” Use 
master facility list to obtain code. 
A15. 
Appointment date at receiving 
facility 
D D M M Y Y Y Y 
Under Referrals: confirm care and treatment services is 
marked, record ‘Date the client is expected at referral 
point.’ 
 B.  Linkage Services Provided at Referring Facility  
 
Data Sources: B3-B5 = EC Daily Register  
B6-B15 = Linkage Register  
WAIT!  If A5 = SHIMS, SKIP TO SECTION C 
B1. Name of data abstractor  Capital letters only; leave blank if same as A1. 
B2. Date of data abstraction  D D M M Y Y Y Y Leave blank if same as A2. 
B3. Client met with EC counselor Yes      No     Unknown  
Check ‘No’ if client is not found on EC Daily Register.  
Check ‘Unknown’ if EC daily register is not found. 
B4. 
EC counselor referred client to care and 
treatment clinic that is different from 
A14 (above) 
Yes      No     Unknown        
Check ‘Unknown’ if EC daily register is not found. 
 
IF NO or UNKNOWN → B6 
B5. If yes, name and code of clinic Name:                                                        Code:  
Capital letters only. 
Use master facility list to obtain code. 
B6. 
EC counselor/APS officer attempted to 
contact the client by telephone   
Yes      No     Unknown        
Check ‘Unknown’ if linkage register is not found.   
 
IF NO or UNKNOWN → C1 
B7. Number of telephone contact attempts _________             Unknown  Check ‘Unknown’ if linkage register is not found. 
B8. Date of first telephone contact attempt D D M M Y Y Y Y IF B7 = 1 → B10 
B9. Date of last telephone contact attempt D D M M Y Y Y Y  
B10. 
EC counselor/APS officer spoke with 
client by telephone 
Yes      No     Unknown  
Check ‘Unknown’ if linkage register is not found. 
 
IF NO or UNKNOWN → C1 
B11. 
Number of times EC counselor/APS 
officer spoke with client by telephone 
_________             Unknown  
Check ‘Unknown’ if linkage register is not found. 
 
B12. 
Date EC counselor/APS officer first 
spoke with client by telephone 
D D M M Y Y Y Y IF B11 = 1 → B14 
B13. 
Date EC counselor/APS officer last 
spoke with client by telephone 
D D M M Y Y Y Y 
 
B14. 
Client reported enrollment in HIV care 
and treatment  
Yes      No     Unknown        
Check ‘Unknown’ if linkage register is not found. 
B15. 
If yes, name and code of clinic where 
client enrolled 
Name:                                                      Code: 
Capital letters only. 
Use master facility list to obtain code. 
 
  
  
C. Linkage Processes at Receiving Facility 
Data Sources:  Expected Patient Binder, Arrived 
Patient Binder,  
Appointment Register, Call Register,  
Pink HTC Referral Forms 
C1. Name of data abstractor  Capital letters only; leave blank if same as A1/B1. 
C2. Date of data abstraction  D D M M Y Y Y Y 
Leave blank if same as A2/B2. 
C3. Name and code of receiving facility Name:                                                      Code: 
Capital letters only. 
Use master facility list to obtain code. 
C4. 
Pink copy of HTC Form is at the 
receiving facility  
Yes      No      
Look at: Expected Patients Binder, Arrived Patients 
Binder 
C5. 
White copy of HTC Form is at the 
receiving facility  
Yes      No      
Look at: Arrived Patients Binder;  Expected Patients 
Binder (if not in Arrived) 
C6. 
Patient is recorded in Appointment 
Register 
Yes      No      
Look at: Appointment Register, check “No” if 
appointment register is not used. 
 
C7. 
Receiving facility staff attempted to call 
client by telephone BEFORE scheduled 
appointment 
Yes      No     
Look at: Call Register, Pink HTC Referral Form, 
Appointment Register 
IF NO → C15 
 
C8. 
Number of telephone contact attempts 
BEFORE appointment 
________                
Look at: Call Register, Pink HTC Referral Form, 
Appointment Register 
C9. 
Date of first call attempt BEFORE 
appointment 
D D M M Y Y Y Y IF C8  = 1 → C11 
C10. 
Date of last call attempt BEFORE 
appointment 
D D M M Y Y Y Y 
 
 
C11. 
Receiving site staff spoke with client by 
telephone BEFORE appointment 
Yes      No                       
Look at: Call Register, Pink HTC Referral Form, 
Appointment Register 
IF NO → C15 
C12. 
Number of times staff spoke with client 
by telephone BEFORE appointment 
________           
 
C13. 
Date staff first spoke with client BEFORE 
scheduled appointment 
D D M M Y Y Y Y IF C12 = 1 → C15 
C14. 
Date staff last spoke with client BEFORE 
scheduled appointment 
D D M M Y Y Y Y 
 
  
C15. 
Receiving site staff attempted to call the 
client by telephone AFTER scheduled 
appointment  
Yes      No              
Look at: Call Register, Pink HTC Referral Form, 
Appointment Register 
IF NO → D1 
C16. 
Number of telephone contact attempts 
AFTER appointment 
________                
 
C17. 
Date of first call attempt AFTER 
appointment 
D D M M Y Y Y Y IF C16 = 1 → C19 
C18. 
Date of last call attempt AFTER 
appointment 
D D M M Y Y Y Y 
 
C19. 
Receiving site staff spoke with client by 
telephone AFTER scheduled 
appointment 
Yes      No                  
Look at: Call Register, Pink HTC Referral Form, 
Appointment Register 
IF NO → D1 
C20. 
Number of times site staff spoke with 
client by telephone AFTER appointment 
_________              
 
C21. 
Date site staff first spoke with client 
AFTER appointment 
D D M M Y Y Y Y IF C20 = 1 → D1 
C22. 
Date site staff last spoke with client 
AFTER appointment 
D D M M Y Y Y Y 
 
D.  Enrollment in HIV Care 
Data Sources:  Pre-ART Register 
Chronic Care File (CCF) 
ART Register 
Laboratory Register  
D1. Name of data abstractor  Capital letters only; leave blank if same as A1/B1/C1. 
D2. Date of data abstraction  D D M M Y Y Y Y Leave blank if same as A2/B2/C2. 
D3. Client recorded in pre-ART register Yes      No       
Look at Pre-ART Register. 
IF NO → D6 
D4. Date of registration in pre-ART register D D M M Y Y Y Y  
D5. Pre-ART patient number   
D6. Client has chronic care file (CCF) Yes      No       
Look for Chronic Care File (CCF). 
IF NO → D9 
D7. Date chronic care file was opened  D D M M Y Y Y Y 
Use ‘Visit Date’ on top right of Pre-ART Enrolment 
Visit form in CCF.  
D8. Patient’s HIV care number  
Use ‘HIV Care No.’ on top left of HIV Care File form in 
CCF. 
WAIT!  If D6 = YES, SKIP TO SECTION E 
  
D9. Client recorded in ART register Yes      No       
Look at ART Register. 
IF NO → D12 
D10. Date of registration in ART register D D M M Y Y Y Y  
D11. ART patient number   
D12. Client recorded in Laboratory Register  Yes      No       
Look at Laboratory Register. 
IF NO → Instructions after D13 
D13. 
Date of registration in Laboratory 
Register 
D D M M Y Y Y Y  
WAIT!  If D3, D6, D9 AND D12 = NO, SKIP TO COMMENT BOX ON PAGE 10 AND END DATA ABSTRACTION! 
E. Clinical Outcomes and Follow-up Visits for Newly Diagnosed Patients    Data Sources:  Chronic Care File (CCF) 
Pre-ART Register, ART Register, Laboratory Register 
E1. Name of data abstractor  
Capital letters only; leave blank if same as 
A1/B1/C1/D1. 
E2. Date of data abstraction  D D M M Y Y Y Y Leave blank if same as A2/B2/C2/D2. 
E3. Patient had psychosocial assessment? Yes      No     
Look at psychosocial assessment form in CCF.  IF NO 
→ E5 
E4. 
Patient responses to select psychosocial 
assessments  
 Y N 
1. Patient disclosed status to family?   
2. Patient disclosed status to partner?   
3. Partner tested for HIV?   
10. Fears discrimination or violence?   
11. Ok for RHM to make home visits?   
12. Patient faces financial challenges   
 
Check one box only in accordance with responses to 
psychosocial assessment in CCF.  Leave both boxes 
blank if specific response is missing on psychosocial 
assessment. 
E5. 
Patient has documented WHO stage in 
chronic care file or HIV register 
Yes      No     
Look at: (1) CCF: ‘WHO stage’ on pre-ART enrollment 
visit form, or ART initiation or follow-up visits forms; 
(2) all other registers noted above as needed.    
IF NO → E8 
E6. Baseline WHO stage I     II      III      IV      
E7. Date of first (baseline) WHO staging D D M M Y Y Y Y  
E8. 
Patient has CD4 cell count recorded in 
chronic care file or HIV register 
Yes      No      
Look at: (1) CCF: ‘CD4+ results’ on pre-ART 
enrollment or follow-up care forms, or ART initiation 
or follow-up visits forms; (2) all other registers noted 
above as needed. 
IF NO → E12 
  
 
  
E9. Baseline CD4 test result ___________     
E10. 
Date of blood draw for baseline CD4 
test  
D D M M Y Y Y Y 
Look at “Date Taken” on pre-ART follow-up visit form, 
lab form, or pre-ART registry. 
E11. Date baseline CD4 test was performed  D D M M Y Y Y Y 
Look at relevant laboratory form in the CCF for the 
baseline CD4 test date. 
E.   Clinical Outcomes and Follow-up Visits for Newly Diagnosed Patients 
Data Sources:  Chronic Care File (CCF) 
Pre-ART Register, ART Register, Laboratory Register 
E12. 
Patient returned to this facility for 
follow-up care and treatment 
Yes      No      
Look at: (1) CCF and (2) all other registers noted 
above as needed. 
IF NO → E25 
E13. Visit 2 after D4/D7 
D D M M Y Y Y Y Check boxes as noted on the follow-up visit form; 
leave both boxes blank if missing.                  CTX: Yes    No        TB screen:  N     P         
E14. Visit 3 after D4/D7 
D D M M Y Y Y Y 
Note: N = negative; P = positive. 
CTX: Yes    No        TB screen:  N     P         
E15. Visit 4 after D4/D7 
D D M M Y Y Y Y 
 
CTX: Yes    No        TB screen:  N     P         
E16. Visit 5 after D4/D7 
D D M M Y Y Y Y 
 
CTX: Yes    No        TB screen:  N     P         
E17. Visit 6 after D4/D7 
D D M M Y Y Y Y 
 
CTX: Yes    No        TB screen:  N     P         
E18. Visit 7 after D4/D7 
D D M M Y Y Y Y 
 
CTX: Yes    No        TB screen:  N     P         
E19. Visit 8 after D4/D7 
D D M M Y Y Y Y 
 
CTX: Yes    No        TB screen:  N     P         
E20. Visit 9 after D4/D7 
D D M M Y Y Y Y 
 
CTX: Yes    No        TB screen:  N     P         
E21. Visit 10 after D4/D7 
D D M M Y Y Y Y 
 
CTX: Yes    No        TB screen:  N     P         
E22. Visit 11 after D4/D7 
D D M M Y Y Y Y 
 
CTX: Yes    No        TB screen:  N     P         
E23. Visit 12 after D4/D7 
D D M M Y Y Y Y 
 
CTX: Yes    No        TB screen:  N     P         
E24. Visit 13 after D4/D7 
D D M M Y Y Y Y 
 
CTX: Yes    No        TB screen:  N     P         
  
 
 
  
E.   Clinical Outcomes and Follow-up Visits for Newly Diagnosed Patients 
Data Sources:  Chronic Care File (CCF) 
Pre-ART Register, ART Register, Laboratory Register 
E25. Patient started ART Yes      No       
Look at: (1) CCF: ART initiation or follow-up visits 
forms; (2) pre-ART or ART registers as needed.  IF NO 
→ E32 
E26. Date patient started ART D D M M Y Y Y Y  
E27. 
Patient has CD4 test result at start of 
ART different from baseline CD4 test 
result (E9)  
Yes      No      
Look at ‘CD4+ results’ on pre-ART enrollment or 
follow-up care forms, or on ART initiation or follow-
up visits forms.  
IF NO → E31 
E28. CD4 test result at start of ART ___________        Unknown  
Look at pre-ART follow-up care or ART initiation visit 
forms, or pre-ART register. 
E29. 
Date of blood draw for CD4 test at start 
of ART 
D D M M Y Y Y Y 
Look at “Date Taken” on pre-ART follow-up care 
form, lab form, or pre-ART register. 
E30. Date CD4 test performed at start of ART D D M M Y Y Y Y 
Look at relevant laboratory form in the CCF for the 
CD4 test date. 
E31. WHO stage at start of ART I     II      III      IV     Unknown  
Look at ART initiation visit form in CCF or pre-ART or 
ART registers as needed. 
E32. 
Patient has CD4 test result in chronic 
care file or HIV register more recent 
than at baseline (E10) or at ART 
initiation (E29) 
Yes      No      
Look at ‘CD4+ results’ on pre-ART enrollment or 
follow-up care forms, or ART initiation or follow-up 
visits forms.  
IF NO → E36 
E33. Most recent CD4 test result ___________         
E34. 
Date of blood draw for most recent CD4 
test  
D D M M Y Y Y Y 
Look at “Date Taken” on pre-ART follow-up visit form, 
lab form, or pre-ART register. 
E35. 
Date most recent CD4 test was 
performed 
D D M M Y Y Y Y 
Look at relevant laboratory form in the CCF for the 
CD4 test date. 
 E.   Clinical Outcomes and Follow-up Visits for Newly Diagnosed Patients 
Data Sources:  Chronic Care File (CCF) 
Pre-ART Register 
E36. Patient transferred out of care Yes      No       
Look under “Outcome” on HIV care file form in CCF; 
pre-ART register (if needed). 
IF NO → E38 
E37. Date patient transferred out  D D M M Y Y Y Y  
E38. Patient died Yes      No       
Look under “Outcome” on HIV care file form in CCF; 
pre-ART register (if needed). 
IF NO → E40 
E39. Date patient died D D M M Y Y Y Y  
E40. Patient lost to follow-up Yes      No       
Look under “Outcome” on HIV care file form in CCF; 
pre-ART register (if needed). 
IF NO → E42 
E41. Date patient lost to follow-up  D D M M Y Y Y Y  
E42. Patient stopped care Yes      No     
Look under “Outcome” on HIV care file form in CCF; 
pre-ART register (if needed). 
IF NO → E44 
E43. Date patient stopped care D D M M Y Y Y Y  
E44. 
Indication in the chronic care file that 
patient was diagnosed with HIV before 
A13 
Yes      No     
Look at HIV care file form in CCF: ‘Date Tested 
Positive,’ ‘Date started ART,’ and ‘Transfer-in.’  
If Yes → Additional Comments and Explain  
 APPENDIX E:  CLINIC CHARACTERISTIC FORM  
GENERAL INSTRUCTIONS 
The Clinic Characteristics Form (CCF) is composed of 2 sections (A, B) that collect information on system- and structural-level characteristics of voluntary medical male 
circumcision (MC) and HIV care and treatment sites that might be associated with early enrollment and retention in care.  Two separate sets of the form will be printed: 
one set will contain only section A (MC), the other set will contain only section B (HIV care and treatment).  For the first set, project staff will use the below data sources 
to complete one form on each of the MC sites included in the program evaluation (n=24).  This set of forms may be completed at the ICAP central office or at MC sites 
by project investigators and clinic staff knowledgeable of site-specific linkage trainings and services provided during the pilot project.  For the second set, project staff 
will use the below data sources to complete one form on each HIV care and treatment site to which randomly selected clients were referred (maximum n=71).  This set 
of forms may be completed, in part, at the ICAP central office by project investigators knowledgeable of site-specific linkage trainings and services provided during the 
pilot project.  To complete Section B, investigators will visit care and treatment sites to obtain required staffing data from the chief medical officer, administrator, or 
designee.  Finally, geocodes of MC and care and treatment sites will be obtained for those sites for which geocodes do not already exist.   
 
DATA SOURCES 
The following data sources will be needed to complete the CCF. 
 Master list of MC site names, codes, and classifications (e.g., mobile or fixed) (Section A only) 
 Master list of HIV care and treatment site names, codes, and classifications (hospital, health center, PHU) (Section B only) 
 Linkage training calendars and participation rosters or summaries 
 HIV care and treatment chief medical officer, administrator, or designee 
 Clinic visit register and Quarter 2 2012 (April-June)  indicator report on new and total pre-ART/ART/LTF patients  (Section B only)  
 GPS unit to obtain site-specific geo-codes if not already available (see corresponding instruction below) 
 
COMPLETION PROCEDURES 
 Complete all items within each section of the CCF in accordance with instructions. 
 Use ink (not pencil) to complete the CCF. 
 Check boxes such that the check is marked through the entire box; ensure that the mark is restricted to only one box. 
 Clearly record site names using capital letters only. 
 Clearly record numeric dates and codes in designated locations (lines or boxes). 
 Re-check all recorded site codes and names against the master list to avoid transcription errors.  
 Re-check recorded geo-codes to avoid transcription errors.  
 Strike through any errors with a single line; record and date your initials next to the line. 
 Site-specific geocodes that already exist may be imported electronically into the project database rather than transcribed onto the CCF.   
  
 
A. Voluntary Medical Male Circumcision Clinic Characteristics 
Data Sources: Master Facility List      
Chief Medical Officer, Administrator, or designee 
 GPS Unit 
A1. Name of data abstractor  Capital letters only. 
A2. Date of data abstraction  D D M M Y Y Y Y  
A3. Name and code of clinic Name:                                                                 Code:  
Capital letters only. 
Use master facility list to obtain code. 
A4. 
Clinic in urban, peri-urban, or rural 
area 
Urban        Peri-urban         Rural   
 
A5. Region of clinic  Hhohho      Lubombo     Manzini     Shiselweni    
A6. Geocode of clinic location  Double check code with GPS unit (if applicable).  
A7. Type of clinic Gov.        Faith-based         Military        Private        Check one type that best applies.   
A8. Clinic classification Fixed         Mobile-tent    
A9. 
Expert client daily register used at 
clinic 
Yes         No            Examine register to confirm use. 
A10. Linkages register used at clinic Yes         No         Examine register to confirm use. 
A11. 
Co-located with HIV care and 
treatment clinic 
Yes         No         IF NO → B1 
A12. 
Name and code of co-located HIV 
care and treatment clinic 
Name:                                                                 Code: 
Capital letters only. 
Use master facility list to obtain code. 
 B. HIV Care and Treatment Clinic Characteristics 
Data Sources: Master Facility List, Clinic Visit Register      
Chief Medical Officer, Administrator or designee 
Q2-2012 Quarterly Indicator Report, GPS Unit 
B1. Name of data abstractor  Capital letters only. 
B2. Date of data abstraction  D D M M Y Y Y Y  
B3. Name and code of clinic Name:                                                                Code:  
Capital letters only. 
Use master facility list to obtain code. 
B4. 
Clinic in urban, peri-urban, or rural 
area 
Urban        Peri-urban         Rural    
B5. Clinic located on a tarred road Yes         No          
B6. Region of clinic  Hhohho      Lubombo     Manzini     Shiselweni    
B7. Geocode of clinic location  Double check code with GPS unit (if applicable). 
B8. Type of clinic Gov.        Faith-based         Military        Private        Check one type that best applies.   
B9. Clinic classification Hospital      Health Center     Clinic       PHU   
B10. Appointment register used at clinic Yes         No            Examine register to confirm use. 
B11. Call register used at clinic Yes         No         Examine register to confirm use. 
B12. Pre-ART register used at clinic Yes         No         Examine register to confirm use. 
B13. ART register used at clinic Yes         No         Examine register to confirm use. 
B14. 
Number of HIV clinic patient visits in 
July 2012  
__________       
Use HIV clinic visit register to count the total 
number of clinic visits for July 2012. 
B15. 
Number of new Q2-2012 (April-June) 
pre-ART, ART, and LTF patients, and 
total (cumulative) active and LTF 
patients. 
Patient Type Q2-2012 Cumulative 
Pre-ART   
ART   
Lost to follow-up (LTF)   
 
Use Q2-2012 Quarterly Indicator Report.  Q2 
refers to new pre-ART, ART, and LTF patients in Q2 
2012.  Cumulative refers to the total number of 
ACTIVE pre-ART and ART patients, and total LTF. 
 B. HIV Care and Treatment Clinic Characteristics 
Data Sources: Master Facility List, Clinic Visit Register      
Chief Medical Officer, Administrator, or designee 
Q2-2012 Quarterly Indicator Report, GPS Unit 
DATA SOURCE FOR FOLLOWING ITEMS: CMO, ADMINISTRATOR, OR DESIGNEE 
B16. 
Days per week that clinic currently 
provides HIV-specific services. 
Mon      Tues      Wed        Thurs       Fri    
                    Saturday       Sunday    
Check only those days in which the clinic provides 
any HIV-specific services (e.g., ART initiation or 
refill).   
B17. 
Change in the number of days per 
week the clinic is open since March 
2011 
 
Increase    Decrease     No change    Unknown   
                                                     
 
B18. 
Average number of providers 
AVAILABLE during days that clinic is 
currently open for NEW  HIV 
patients. 
          Cadre # Available 
Doctor  
Nurse  
Counselor  
Lay Counselor  
EC Counselor  
 
This item measures current average daily staffing 
when the clinic sees new patients. Ask the chief 
medical officer, administrator, or designee to 
exclude days that the clinic sees only a subset of 
patients such as on ARV refill days. 
B19. ART initiated on site Yes         No          
B20. ART refills provided on site Yes         No          
B21. Cadre who initiate ART Doctor          Nurse             N/A                 
Check only those clinicians who are permitted to 
initiate patients on ART. 
B22. 
Phone available for defaulter tracing 
calls 
Yes         No        Unknown       IF NO → B25 
B23. 
Average monthly airtime/credit 
available to conduct defaulter 
tracing calls 
______ Credit (Emalengeni) Unlimited        Unk.      
Check unlimited if an upper limit on airtime usage 
for defaulter tracing calls does not exist. 
B24. 
Staff who conduct defaulter tracing 
calls 
     Doctor          Nurse            Counselor       
                       Lay/EC Counselor    
Check all that apply. 
B25. 
Clinic staff trained on SOP in 2011 
and 2012 
Yes, 2011    Yes, 2012    Neither yr.    Unknown     
Check both if applicable. 
IF NEITHER YR → END 
B26. 
Number of SOP trainings received in 
2011 and 2012 
   ____ 2011     ____ 2012    Unk. 2011     Unk. 2012        
 APPENDIX F: DATA SOURCE AND QUALITY FORM 
I.  Site Abstraction Process Indicators 
 
Site: ________________________________________________ Submission Date: _______________ 
 
1.  Abstraction Visit Dates         
Date Supervisor Date Supervisor 
    
    
 
2.  Registers Available [Complete table for ART register, both primary registers, and alternate registers if 
primary registers are not available for all years.] 
Registers Available 2011 2012 2013 
ART Register  Y          N Y          N Y          N 
Appointment Register (Primary) Y          N Y          N Y          N 
Pre-ART Register (Primary) Y          N Y          N Y          N 
Laboratory Register (Alternate) Y          N Y          N Y          N 
Pharmaceutical Register (Alternate) Y          N Y          N Y          N 
Clinic Attendance Register (Alternate) Y          N Y          N Y          N 
 Y          N Y          N Y          N 
 Y          N Y          N Y          N 
 
3.  Missing Dates  
Registers Available Missing Dates 2011 Missing Dates 2012 Missing Dates 2013 
ART Register    
Appointment Register    
Pre-ART Register    
 
4.  Registers Reviewed 
Registers Reviewed  2011 2012 2013 
ART Register Y          N Y          N Y          N 
Appointment Register (Primary) Y          N Y          N Y          N 
Pre-ART Register (Primary) Y          N Y          N Y          N 
Laboratory Register (Alternate) Y          N Y          N Y          N 
Pharmaceutical Register (Alternate) Y          N Y          N Y          N 
 Y          N Y          N Y          N 
 Y          N Y          N Y          N 
 
5.  Other Data Sources  
Other Data Sources Available Used 
Electronic Medical Record System Y          N Y          N 
HIV clinic Expert Clients Y          N Y          N 
Call Register Y          N Y          N 
Pink HTC forms  Binder      Other      None Y          N 
White HTC forms  Binder      Other      None Y          N 
Chronic Care File Chart Review (Chart Room) Y          N Y          N 
 
  
 II.  Data Source & Abstraction Quality 
EMR Sites 
Code Data Sources Reviewed for Complete-queried EMR Sites 
A Duplicate, Primary Register Review:  Appointment and Pre-ART registers available for all years and have 
complete coverage of dates for each year 2011, 2012, and 2013.   
A1E All years reviewed with both primary registers; ART registers reviewed for all years. 
A2E All years reviewed with both primary registers; ART registers reviewed for some time interval. 
A3E All years reviewed with both primary registers; ART register not available. 
B Duplicate, Mixed Register Review:  Primary registers not available for all years or have missing dates of 
coverage.  Alternate registers used to cover date gaps with two eligible data sources. 
B1E All years reviewed with two eligible registers; ART registers reviewed for all years. 
B2E All years reviewed with two eligible registers; ART registers reviewed for some time interval. 
B3E All years reviewed with two eligible registers; ART register not available. 
C Single Register Review:  Primary and alternate registers are not available for all years or have missing dates 
of coverage.  A single eligible register is used to cover one or more date gaps.  
C1E <1 year reviewed with single eligible register; remainder with two; ART registers reviewed for all years. 
C2E >1 year reviewed with single eligible register; any remainder with two; ART registers reviewed for all years. 
C3E Any interval reviewed with single eligible register; any remainder with two; ART registers for none or some int. 
D Incomplete Register Review: Primary or alternate registers are not available for all years or have missing 
dates of coverage.  One or more date gaps are not reviewed with any eligible register. 
D1E <1 year without primary and alternate register review; ART registers reviewed for all years. 
D2E >1 years without primary and alternate register review; ART registers reviewed for all years. 
D3E Any interval without primary and alternate register review; ART registers reviewed for none or some interval. 
 
Non-EMR Sites 
Code Data Sources Reviewed for Incomplete-queried or Non-EMR Sites 
A Duplicate, Primary Register Review:  Appointment and Pre-ART registers available for all years and have 
complete coverage of dates for each year 2011, 2012, and 2013.   
A1 All years reviewed with both primary registers; ART registers reviewed for all years. 
A2 All years reviewed with both primary registers; ART registers reviewed for some time interval. 
A3 All years reviewed with both primary registers; ART register not available. 
B Duplicate, Mixed Register Review:  Primary registers not available for all years or have missing dates of 
coverage.  Alternate registers used to cover date gaps with two eligible data sources. 
B1 All years reviewed with two eligible registers; ART registers reviewed for all years. 
B2 All years reviewed with two eligible registers; ART registers reviewed for some time interval. 
B3 All years reviewed with two eligible registers; ART register not available. 
C Single Register Review:  Primary and alternate registers are not available for all years or have missing dates 
of coverage.  A single eligible register is used to cover one or more date gaps.  
C1 <1 year reviewed with single eligible register; remainder with two; ART registers reviewed for all years. 
C2 >1 year reviewed with single eligible register; any remainder with two; ART registers reviewed for all years. 
C3 Any interval reviewed with single eligible register; any remainder with two; ART registers for none or some int. 
D Incomplete Register Review: Primary or alternate registers are not available for all years or have missing 
dates of coverage.  One or more date gaps are not reviewed with any eligible register. 
D1 <1 year without primary and alternate register review; ART registers reviewed for all years. 
D2 >1 years without primary and alternate register review; ART registers reviewed for all years. 
D3 Any interval without primary and alternate register review; ART registers reviewed for none or some interval. 
 
  
 III.  DAF Process Outcomes 
1.  Data Source & Abstraction Code: _______ 
2.  SHIMS DAFs Assigned: _______ 
3.  Soka DAFs Assigned: _______  
4.  DAFs Completed: _______ 
5.  DAFs reviewed for legibility, completeness, and consistency: _______ 
6.  DAFs returned to staff for clarification or corrections: ________ 
 
IV. Enrollment Outcomes 
1.  Number of clients (DAFs) who enrolled in care at this clinic: _______  
2.  Number of enrolled clients HIV diagnosed before SHIMS/SOKA indicated in register or CCF: _______ 
3.  Revised number of enrolled clients newly HIV diagnosed during SHIMS/SOKA: _______ 
4.  Revised newly diagnosed enrolled in care with Chronic Care File: ________ 
5.  Data sources used to identify clients who enrolled in care:  [Complete table if at least one client 
enrolled in care.] 
Data Sources  
 
Data Source 
Code 
Enrolled 
Clients 
Electronic Medical Record System EMR  
HIV Clinic Expert Clients ECS  
Other Clinic Staff [Identify Staff]:  OCS  
Appointment Register  APT  
Pre-ART Register PRE  
Laboratory Register  LAB  
Pharmaceutical Register  PHA  
ART Register ART  
Chronic Care File Chart Review   CCF  
Other [Identify]: OTH  
Other [Identify]: OTH  
Total clients enrolled in care [sum must equal #1 above.]   
  
  
APPENDIX G:  DEFAULTER TRACING FORM 
GENERAL INSTRUCTIONS 
The Defaulter Tracing Form (DTF) is composed of 6 sections (A-F) that collect information on persons responsible for contacting clients who did not enroll in HIV care 
and treatment (defaulters); key processes and outcomes of tracing defaulters by telephone; whether contacted defaulters enrolled at other care and treatment sites 
and reasons for doing so (if applicable); and for those who report not enrolling in care, reasons for not enrolling and intentions to enroll in care.  One DTF will be 
completed on each client determined not to have enrolled at the HIV care and treatment site to which he/she was referred (determination based on Data Abstraction 
Form).  Trained linkage-to-care or care and treatment staff will call defaulters and complete the DTF after obtaining client consent to conduct the brief study.  Client 
verbal consent will be obtained using the telephone script provided below.  Only defaulters who gave permission to be contacted, as recorded on the HTC or data 
abstraction form, will be called.  Required data sources, and DTF completion, storage, notification, and administration procedures are provided below.  
 
DATA SOURCES 
The following data sources will be needed to complete the DTF: 
 Completed Data Abstraction Forms that identify which clients might be eligible for defaulter tracing. 
 Copies of HTC forms on identified defaulters who gave permission to be contacted by phone (SHIMS only). 
 Master list of HIV care and treatment facilities. 
 
COMPLETION PROCEDURES 
 Use ink (not pencil) to complete the DTF. 
 Check boxes such that the check is marked through the entire box; ensure that the mark is restricted to only one box. 
 Clearly record names using capital letters only. 
 Clearly record numeric dates in designated locations (lines or boxes). 
 Re-check all recorded names against the HTC or data abstraction form and master list of care and treatment facilities to avoid transcription errors.  
 Re-check dates and times to avoid simple errors. 
 Strike through any errors with a single line; record and date your initials next to the line.    
 
FORM MANAGEMENT PROCEDURES  
 Maintain files of completed forms in a secure office with limited controlled access until submission to the data manager for data entry.  
 Completed forms transported to the ICAP central office will be transported in a locked portable file.  Forms will be hand delivered only to the ICAP data 
manager or designee. 
 Section DTF ADMINISTRATION PROCEDURES 
A 
Section A collects defaulter tracing management information. 
 Complete A1 – A4 before attempting to contact identified defaulters (clients). 
 Complete A5 only after the client has been contacted or after all contact attempts are exhausted AND all items on the DTF have been completed.   
B 
Section B is a script to read to the client after contact is made.  It introduces the interviewer, explains the study and why they are being contacted, and obtains 
consent to conduct the interview.  The script must be read word-for-word.  When finished, mark the box to indicate if the client agrees to participate or not, 
then sign and date the consent form. 
C 
Section C collects information on whether defaulters were contacted by SMS, telephone, or in person in accordance with the National SOP. 
 Assess whether the client was ever contacted by the clinic through SMS, phone call, or visit. 
D 
Section D collects information on whether defaulters enrolled in care and reasons for enrolling at a different facility (if applicable) 
 Assess whether the client enrolled in care at any HIV care and treatment facility, and record the name of that facility (if applicable).  Use the list of facilities 
to avoid misspellings. 
 For those clients who enrolled in care but not at the facility to which they were referred, assess the reasons they enrolled at a different facility.  DO NOT 
READ THE LIST OF POTENTIAL REASONS.  Only ask why they chose not to enroll at the facility to which they were referred and circle one or more numbers 
that correspond best with their response.  Ask once if there are other reasons for not enrolling at the facility to which they were referred, and circle again 
one or more numbers that correspond best with their response. 
 For clients who reported enrolling in HIV care and treatment, record any additional information on barriers or facilitators in contacting the client or on their 
enrollment into HIV care; complete and store the DTF, and notify the project coordinator in accordance with the above procedures. 
E 
Section E collects information on why defaulters have not enrolled in HIV care at any facility and intentions to enroll in care. 
 For those clients who have not yet enrolled in HIV care, ask why they haven’t enrolled and circle one or more numbers that correspond best with their 
response.  DO NOT READ THE LIST OF POTENTIAL REASONS.  Ask once if there are other reasons for not enrolling and circle again one or more numbers 
that correspond best with their response. 
 Assess whether the client intends to enroll in care in the next 12 months.  Record the name of the facility (if applicable).   
 Underscore the value of enrolling in care and completing their enrollment, and identify and address real or perceived barriers to care. 
 Record any additional information on barriers or facilitators in contacting the client or on their enrollment into HIV care; complete and store the DTF, and 
notify the project coordinator in accordance with the above procedures.  
F 
Section F collects information on the dates and times that calls were made to reach the client or client next of kin. 
 Vary the day and time of calling clients: attempt at least one early morning and one late-afternoon call (if needed). 
 After three unsuccessful attempts to call the client have been made, call the next of kin (if number is provided on the HTC form or DAF). 
 In calling the next of kin, protect the client’s confidentiality in accordance with standard defaulter-tracing procedures: never disclose the clients’ test 
results.  Leave a message for the client with the next of kin in accordance with standard procedures.   
 For clients who were not contacted by phone, record any additional information on barriers to contacting the client or information on their potential 
disposition provided by the next of kin; complete and store the DTF, and notify the project coordinator in accordance with the above procedures.   
 
 
 
  
  
 
 
A.  Defaulter Tracing Management 
Data Source: HTC form or DAF  
Master Facility List      
A1. 
Person responsible for calling client and 
completing this form 
Name:                                                       Capital letters only. 
A2. 
HTC form number (N) including initial 
letter (L) 
L N N N N N N 
The number is located in the upper right hand corner of 
HTC form or DAF A3, include letter and all zeros. 
A3. Name of first referral HIV clinic Name:                                                       
The referral clinic is at the bottom of the HTC form. In 
rare cases, two clinics might be noted. 
A4. Name of second referral HIV clinic Name: 
Leave blank if only one clinic is noted. Second referral 
clinic will be written on the HTC form or DAF. 
A5. Date form completed D D M M Y Y Y Y  
 
  
  
 
[READ THIS CONSENT SCRIPT IN ACCORDANCE WITH INSTRUCTIONS.  WHEN FINISHED, INDICATE IF THE CLIENT AGREES TO PARTICIPATE OR NOT, THEN SIGN AND DATE THE 
FORM.]  
 
Introduction 
Hello, my name is___________, and I am calling on behalf of [ORGANIZATION] and the Ministry of Health.  Am I speaking with __________(first and last name)?   
 
When you participated in [Swaziland HIV Incidence Measurement Survey (SHIMS)/SOKA UNCOBE], you gave permission to be contacted by telephone for follow-up services.  If it 
is ok, I would like to explain why I’m calling you.     
 
[IF NEEDED, CONFIRM PARTICIPATION IN SHIMS OR SOKA UNCOBE.  PROCEED ONLY IF FULL NAME AND PARTICIPATON IN SHIMS/SOKA UNCOBE MATCH THE HTC OR DATA 
ABSTRACTION FORM.  IF IDENTITY IS NOT CONFIRMED, APOLOGIZE FOR THE MISTAKE, THANK THE PERSON FOR HIS/HER TIME, AND END THE CALL.  
 
[IF CLIENT SAYS IT IS OK, PROCEED; OTHERWISE, THANK THE CLIENT FOR HIS/HER TIME AND END THE CALL.] 
 
Purpose 
I’m calling you because the Ministry of Health, supported by Columbia University ICAP, Population Services International, and the Centers for Disease Control and Prevention, is 
conducting a research study to learn about medical services clients may have received after testing for HIV in __________[SHIIMS/SOKA UNCOBE].   
 
Privacy 
Before we proceed, are you in an area that is private and that you can speak freely and comfortably without being overheard?   
 
[DO NOT PROCEED IF CLIENT CANNOT SPEAK PRIVATELY; IF NEEDED, MAKE AN APPOINTMENT TO CALL BACK WHEN CLIENT CAN SPEAK PRIVATELY.] 
 
Procedures 
Your participation in this research study is important for helping the Ministry of Health improve HIV services.  With your consent, I will ask you a few questions about medical 
services you may have received after testing for HIV in [SHIMS/SOKA UNCOBE].  The questions will take about 5 minutes of your time.  Before I ask you these questions, I must 
read information about the study and your rights, and then ask for your consent to participate.  May I begin?  
 
Confidentiality 
All information you give during this study will be kept confidential and your name will be kept separate from your answers.  Researchers from the Ministry of Health, Columbia 
University Medical Center, Population Services International, the Office of Human Research Protection, and the Centers for Disease Control and Prevention may examine study 
records to ensure we are protecting your rights as a study participant. Findings from this research study will be presented at meetings and published in national reports and 
scientific journals. 
 
Voluntariness  
You do not have to participate in this study, and you may stop at any time.  If you decide to participate, you don’t have to answer any questions you don’t want to answer.  If you 
decide not to participate, or if you decide to stop, you will not suffer any harm and you will not be denied any services. 
 
B. Defaulter Tracing Consent Script  
  
Potential Harm 
If you participate, you may feel uncomfortable about answering some questions that I will ask you.  There is some risk that persons outside this study may learn information that 
you share.  However, all members of the study are given special training on ways to keep information private.  All interviewers, including myself, also take an oath to keep all 
information collected in this study private.  
 
Potential Benefits 
By participating in this study, you may help improve HIV services in Swaziland, which could benefit you or someone you know in the future.  
 
Contact Information 
Should you have any general questions about this study, you may contact Dr. Charles Azih from the Ministry of Health at +268 7607 8171.  You may also contact the Swaziland 
Scientific and Ethics Committee Secretariat at 24047712 or 24045469 if you have any questions about your rights as a research participant, questions regarding research-related 
harm, or if you feel you have been harmed as a result of your participation.  You may also contact Columbia University Medical Center in New York at 001-212 305-5883. 
 
Do you have any questions or concerns about participating in this study?  
 
[ANSWER ALL QUESTIONS OR CONCERNS BEFORE PROCEEDING] 
 
Would you like to participate in this Ministry of Health study?   
 
   YES, the client agrees to participate. 
 
   NO, the client declines to participate. 
 
Name of Interviewer:   ___________________________________________ 
 
Date of Consent:   [_D_|_D_]-[_M_|_M_]-[_Y_|_Y_| Y_|_Y_] 
 
[IF THE CLIENT CONSENTS, THANK THE CLIENT FOR HIS PARTICIPATION AND BEGIN THE STUDY AT C1.  IF THE CLIENT DECLINES, THANK THE CLIENT FOR HIS/HER TIME AND END 
THE CALL.]  
  
 
C.  Follow-up Services by Referral Clinic   
C1. 
When you tested for HIV in [SHIMS/SOKA UNCOBE], do you 
remember if you were referred for HIV care?  
Yes      No       IF NO → C3 
C2. To which clinic were you referred for HIV care?  Name:  This clinic may be different from (A3). 
C3. 
Did you ever receive an SMS text reminder to enroll in HIV care 
at _______________________[A3]? 
Yes      No      Unknown          
C4. 
Did you ever receive a phone call from a representative from 
[A3] about enrolling in HIV care? 
Yes      No      Unknown   IF NO OR UNKNOWN → C6 
C5. 
Did you ever speak by telephone with a representative from 
[A3] about enrolling in HIV care? 
Yes      No      Unknown    
C6. 
Did a representative from [A3] ever visit your home to speak 
with you?  
Yes      No      Unknown   
IF NO OR UNKNOWN → INSTRUCTIONS 
AFTER C7 
C7. 
Did you ever speak at home with a representative from [A3] 
about enrolling in HIV care? 
Yes      No      Unknown    
REFER TO A4: IF A SECOND REFERAL HIV CLINIC IS NOTED, ADMINISTER C8-12; OTHERWISE SKIP TO D1 
 
 
C.  Follow-up Services by Referral Clinic   
C8. 
Did you ever receive an SMS text reminder to enroll in HIV 
care at _______________________________[A4]? 
Yes      No      Unknown          
C9. 
Did you ever receive a phone call from a representative from 
[A4] about enrolling in HIV care? 
Yes      No      Unknown   IF NO OR UNKNOWN → C11 
C10. 
Did you ever speak by telephone with a representative from 
[A4] about enrolling in HIV care? 
Yes      No      Unknown    
C11. 
Did a representative from [A4] ever visit your home to speak 
with you?  
Yes      No      Unknown   IF NO OR UNKNOWN → D1 
C12. 
Did you ever speak at home with a representative from [A4] 
about enrolling in HIV care? 
Yes      No      Unknown   CONTINUE TO NEXT SECTION 
 
  
  
 
D.  Enrollment in Care   
D1. 
Did you ever enroll in HIV care and 
treatment? 
Yes      No       IF NO → E1 
D2. 
Where did you enroll for HIV care and 
treatment? 
Name:                                                                                 This clinic may be different than A3/A4. 
D3. 
What month and year did you enroll for 
HIV care at _____________[D2]? 
 M M Y Y Y Y 
Help client remember month of 
enrollment; leave blank if unknown. 
D4. 
At which clinic did you last receive HIV 
care?  
Name:                                                                            
This clinic may be different than A3/A4 
and D2. 
D5. 
What month and year did you last 
receive HIV care at __________[D4]?      
 M M Y Y Y Y 
Help client remember month of 
enrollment; leave blank if unknown. 
D6. 
[DO NOT ASK] Is D2 different from 
[A3/A4]? 
Yes      No       IF NO → INSTRUCTIONS AFTER D7 
D7. Why did you decide to enroll in HIV care 
at [D2] and not at 
_______________________[A3/A4]?  
 
[ASK ONCE MORE ONLY]   
 
Are there any other reasons you decided 
to enroll in HIV care at [D2] and not at 
_______________________[A3/A4]?  
 
COSTS LESS FOR HIV CARE AT THIS CLINIC 01  
DO NOT READ RESPONSE OPTIONS TO 
CLIENT.   
 
Circle all responses that apply.    
 
 
COSTS LESS FOR TRANSPORT AT THIS CLINIC  02 
CLIENT LIVES CLOSER TO THIS CLINIC 03 
CLIENT LIVES FURTHER AWAY FROM THIS CLINIC 04 
CLIENT DOES NOT KNOW PEOPLE AT THIS CLINIC 05 
CLIENT KNOWS PEOPLE AT THIS CLINIC 06 
FAMILY/FRIENDS  WANT CLIENT TO ATTEND THIS CLINIC 07 
CLIENT HAS GREATER TRUST IN PROVIDERS AT THIS CLINIC 08 
HEALTH CARE STAFF ARE MORE RESPECTFUL AT THIS CLINIC 09 
PATIENTS RECEIVE BETTER CARE AT THIS CLINIC 10 
CLIENT HAS SHORTER WAIT TO SEE A PROVIDER AT THIS CLINIC 11 
OTHER:      
12 
DOESN’T KNOW 99 
CONGRATULATE AND THANK CLIENT FOR ENROLLING IN CARE AND SPEAKING WITH YOU. END CALL, COMPLETE THE TELEPHONE LOG (SECTION F), AND WRITE ANY 
ADDITIONAL COMMENTS ON PAGE 11. 
 
  
  
 
E.  Reasons & Intentions   
E1. Why haven’t you gone to a clinic to 
enroll in and receive HIV care? 
 
[ASK ONCE MORE ONLY]   
 
Are there any other reasons you 
haven’t gone to a clinic to enroll in 
and receive HIV care?   
 
 
 
NO TIME, TOO BUSY  01  
 
 
DO NOT READ RESPONSE OPTIONS TO 
CLIENT.   
 
Circle all responses that apply.    
 
 
 
CLIENT DOES NOT KNOW WHERE CLINIC IS 02 
COSTS TOO MUCH FOR HIV CARE 03 
COSTS TOO MUCH FOR TRANSPORT  04 
CLIENT LIVES TOO FAR AWAY 05 
CLIENT IS FEELING WELL, HAS NO NEED TO GO TO HIV CLINIC 06 
CLIENT IS BEING TREATED BY TRADITIONAL HEALER 07 
FAMILY/FRIENDS DO NOT WANT CLIENT TO GO TO HIV CLINIC 08 
CLIENT DOES NOT BELIEVE HIV TREATMENT IS EFFECTIVE 09 
CLIENT BELIEVES HIV TREATMENT HAS SEVERE SIDE EFFECTS 10 
CLIENT DOES NOT TRUST THE HIV CARE PROVIDERS 11 
HEALTH CARE STAFF AT HIV CLINIC ARE DISRESPECTFUL 12 
PATIENTS RECEIVE POOR QUALITY OF CARE AT HIV CLINIC 13 
CLIENT HAS TO WAIT TOO LONG TO SEE A PROVIDER 14 
 CLIENT DOES NOT WANT PEOPLE TO KNOW HE/SHE HAS HIV 15 
OTHER: 
16 
DOESN’T KNOW 99 
E2. Would you like to enroll in HIV care?    Yes      No      Unknown   
IF NO OR UNKNOWN → INSTRUCTIONS 
AFTER E5 
E3. 
Where would you like to enroll for 
HIV care? 
Name:                                                                                      
Capital letters only. Use master facility 
list. 
E4. 
Can I make an appointment for you 
at [E3]?  To do this, I will send your 
referral form to [E3] with a revised 
appointment date. 
Yes      No       
IF NO OR UNKNOWN → INSTRUCTIONS 
AFTER E5 
E5.  Appointment date D D M M Y Y Y Y 
Date should not be more than 2 weeks 
from date of call with client. 
ADDRESS REASONS FOR NOT ENROLLING IN CARE. CONVEY IMPORTANCE AND ENCOURAGE ENROLLMENT IN HIV CARE.  END CALL, COMPLETE THE TELEPHONE LOG 
(SECTION F), AND WRITE ANY ADDITIONAL COMMENTS ON PAGE 11. 
 
  
  
F.  Telephone Log – Update after each call   
F1. Date of first call attempt. D D M M Y Y Y Y  
F2. Telephone number is active? Yes      No       IF NO → F10 
F3. Spoke with client? Yes      No       IF NO → F10 
F4 Consent script read to client? Yes      No       IF NO → F7 
F5. Client gave consent for interview? Yes      No       IF NO → COMMENTS and END TRACING 
F6. Interview completed? Yes      No       IF YES → COMMENTS and END TRACING 
F7. Client agreed to be called back? Yes      No   IF NO → COMMENTS and END TRACING 
F8. Date scheduled for follow up call. D D M M Y Y Y Y Leave blank if date was not scheduled. 
F9. Time scheduled for follow-up call. H H M M  Leave blank if time was not scheduled. 
 
F10. Date of second call attempt. D D M M Y Y Y Y  
F11. Telephone number is active? Yes      No       IF NO →F19 
F12. Spoke with client? Yes      No       IF NO → F19 
F13. Consent script read to client? Yes      No       IF NO → F16 
F14. Client gave consent for interview? Yes      No       IF NO → COMMENTS and END TRACING 
F15. Interview completed? Yes      No       IF YES → COMMENTS and END TRACING 
F16. Client agreed to be called back? Yes      No   IF NO → COMMENTS and END TRACING 
F17. Date scheduled for follow up call. D D M M Y Y Y Y Leave blank if date was not scheduled. 
F18. Time scheduled for follow-up call. H H M M     Leave blank if time was not scheduled. 
  
 
F19. Date of third call attempt. D D M M Y Y Y Y  
F20. Telephone number is active? Yes      No       IF NO → INSTRUCTIONS AFTER F27 
F21. Spoke with client? Yes      No       IF NO → INSTRUCTIONS AFTER F27 
F22. Consent script read to client? Yes      No       IF NO → F25 
F23. Client gave consent for interview? Yes      No       IF NO → COMMENTS and END TRACING 
F24. Interview completed? Yes      No   IF YES → COMMENTS and END TRACING 
F25. Client agreed to be called back? Yes      No   IF NO → COMMENTS and END TRACING 
F26. Date scheduled for follow up call. D D M M Y Y Y Y Leave blank if date was not scheduled. 
F27. Time scheduled for follow-up call. H H M M  Leave blank if time was not scheduled. 
NOTE: CALL NEXT OF KIN ONLY IF CONSENT WAS GIVEN ON HTC OR DATA ABSTRACTION FORM 
F28. 
Telephone number of next of kin is 
active? 
Yes      No       IF NO → COMMENTS and END TRACING. 
F29. Spoke with next of kin? Yes      No       IF NO → COMMENTS and END TRACING. 
F30. Date spoke with next of kin. D D M M Y Y Y Y  
F31. 
[DO NOT ASK; RECORD IF MENTIONED]  
Client lives in different country? 
Yes      No      Unknown        IF YES → COMMENTS and END TRACING. 
F32. 
DO NOT ASK; RECORD IF MENTIONED]  
Client is deceased?  
Yes      No      Unknown        IF YES → COMMENTS and END TRACING. 
F33. 
Next of kin agreed to help contact 
client? 
Yes      No      Unknown         
F34. 
Spoke with client after call with next of 
kin? 
Yes      No       IF NO → COMMENTS and END TRACING. 
F35. Date spoke with client D D M M Y Y Y Y → COMMENTS 
 
 APPENDIX H:  STUDY PERSONNEL ROSTER 
Position Name 
  
Project Coordinator Nosipho Storer 
  
Deputy Project Coordinator Nontobeko Dlamini 
  
Facility Coordinator Nolwazi Bhebhe 
  
Data Management Supervisor Lungile Nkambule 
  
Data Entry Specialists Lancelot Ndlovu 
 Veli Madau 
  
Field Supervisors Dan Nxumalo 
 Musa Tamhla 
 Nomsa Mavimbela 
 Siphiwangubani Sikhondze 
 Zethu Mansoor 
  
Data Abstractors Banele Mohale 
 Bongile Dlamini 
 Gugulethu Nozipho Gule  
 Mandisa Zwane 
 Mark Mngomezulu 
 Mkhosi Mdluli 
 Mphikeleli Dlamini 
 Mthulisi Moyo 
 Ndumiso Dlamini 
 Nelisiwe Masilela 
 Nokuphila Magagula 
 Nomkhosi Magagula 
 Phetsile Ndabandaba 
 Sibusiso Matsenjwa 
 Sicelo Dlamini 
 Sindie Silindza 
 Siphesihle Shongwe 
 Thabile Dlamini 
 Thembela Nkambule 
 Zamokuhle Mahlangu 
 Zenani Mavuso 
  
Interviewers Jabulile Mgodlola 
 Makhanya Buisilie 
 
 APPENDIX I:  FACILITIES VISITED TO ASSESS ENROLLMENT IN HIV CARE1 
Region     Facility Name & Classification       Type2 Location2  Referral3      Enrollment4 
Hhohho      
 Mbabane Government Hospital Government Urban Referral Yes 
 Pigg's Peak Government Hospital Government Urban Referral Yes 
 Dvokolwako Health Center Government Rural Referral Yes 
 Mkhuzweni Health Center Government Rural Referral Yes 
 Baylor Clinic Private Urban Alternate Yes 
 Bhalekane Nazarene Clinic Faith-based Rural Referral Yes 
 Bulandzeni Clinic Government Rural Referral Yes 
 Bulembu (Havelock) Clinic Private Rural Alternate Yes 
 Giving Life Clinic  Private Peri-urban Alternate Yes 
 Herefords Clinic Government Rural Referral Yes 
 Horo Clinic Government Rural Referral Yes 
 Lobamba Clinic Government Peri-urban Referral Yes 
 Maguga Clinic Government Rural Referral No 
 Mahwalala Red Cross Clinic NGO5 Urban Referral Yes 
 Malandzela Nazarene Clinic Government Rural Alternate Yes 
 Mangweni Clinic Government Rural Referral Yes 
 Mbabane Clinic Private Urban Alternate No 
 Medisun Clinic Private Urban Alternate Yes 
 Motshane Clinic Government Peri-urban Referral Yes 
 Ndvwabangeni Nazarene Clinic Faith-based Rural Referral Yes 
 Nkaba Clinic Government Rural Alternate Yes 
 Ntfonjeni Clinic Government Rural Referral Yes 
 Salvation Army Clinic Faith-based Urban Referral No 
 Satellite Clinic Government Urban Referral No 
 Siphocosini Clinic Government Rural Referral Yes 
Lubombo      
 Good Shepherd Hospital Faith-based Peri-urban Referral Yes 
 Ubombo Sugar Hospital Private Peri-urban Referral Yes 
 Sithobela Rural Health Center Government Rural Referral Yes 
 Bholi Clinic Government Peri-urban Referral Yes 
 Ebenezer Clinic Faith-based Rural Alternate No 
 Embutfu Clinic Private Rural Alternate Yes 
 Gilgal Clinic Government Rural Referral Yes 
 Lubuli Clinic Government Rural Referral Yes 
 Mhlume Clinic Private Peri-urban Referral No 
 Mafutseni Nazerene Clinic Faith-based Rural Alternate Yes 
 Manyeveni Nazarene Clinic Faith-based Rural Alternate Yes 
 Mpolonjeni Clinic Government Rural Referral Yes 
 Ndzevane Community Clinic Government Rural Referral Yes 
 Nkalashane Community Clinic Government Rural Alternate Yes 
 Simunye Lusoti Clinic Private Peri-urban Referral Yes 
 Shewula Nazarene Clinic Faith-based Rural Referral Yes 
 Sinceni Clinic Government Rural Referral Yes 
  
 Siphofaneni Clinic Government Rural Referral Yes 
 Tabankulu Estates Clinic Private Rural Referral Yes 
 Tikhuba Clinic Government Rural Referral Yes 
 Vuvulane Clinic Government Rural Referral Yes 
 Siteki Public Health Unit Government Rural Alternate No 
Manzini      
 Mankayane Government Hospital Government Rural Referral Yes 
 National TB Hospital Government Peri-urban Alternate Yes 
 Raleigh Fitkin Memorial Hospital Faith-based Urban Referral Yes 
 Cana Alliance Clinic Faith-based Rural Referral Yes 
 Private Doctor’s Clinic6 Private Urban Alternate Yes 
 Private Doctor’s Clinic6 Private Urban Alternate Yes 
 Dwalile Clinic Government Rural Alternate No 
 Family Life Association Clinic NGO5 Urban Referral Yes 
 Gebeni Clinic Government Rural Referral Yes 
 Lamvelase AHF Clinic Private Urban Referral Yes 
 Lamvelase (Zombodze) Clinic  Government Peri-urban Referral Yes 
 Luyengo Clinic Government Peri-urban Referral Yes 
 MSF Matsapha Clinic Private Urban Alternate Yes 
 Mbikwakhe Clinic Faith-based Peri-urban Alternate Yes 
 Mkhulamini Clinic Government Rural Referral Yes 
 Mliba Nazarene Clinic Faith-based Rural Referral Yes 
 Mpuluzi Clinic Government Rural Referral No 
 Musi Clinic Government Rural Referral Yes 
 Ngculwini Nazarene Clinic Faith-based Rural Alternate Yes 
 Phocweni U.S.D.F Clinic Military Peri-urban Referral Yes 
 Sibovu Clinic  Government Rural Referral Yes 
 Sigcineni Clinic Government Rural Referral Yes 
 St. Theresa's Clinic Faith-based Urban Referral No 
 King Sobhuza II Public Health Unit Government Urban Referral Yes 
Shiselweni      
 Hlatikhulu Hospital Government Rural Referral Yes 
 Matsanjeni Health Center Government Rural Referral Yes 
 Nhlangano Health Center Government Urban Referral Yes 
 Dwaleni Clinic Government Peri-urban Referral Yes 
 Gege Clinic Government Rural Referral Yes 
 Hluti Clinic Government Rural Referral Yes 
 JCI (Mphelandzaba) Clinic Government Rural Referral Yes 
 Jericho Clinic Government Rural Referral Yes 
 Kamfishane (Kandlovu) Clinic Government Rural Referral Yes 
 Lavumisa Clinic Government Urban Referral Yes 
 Magubheleni Clinic Faith-based Rural Referral Yes 
 Mahlandle Clinic Government Rural Referral Yes 
 Mashobeni Clinic Government Rural Referral Yes 
 Mhlosheni Clinic Government Rural Alternate No 
 Moti Clinic Government Rural Alternate Yes 
 New Haven Clinic Government Rural Referral Yes 
  
 Nhletsheni Clinic Government Rural Referral Yes 
 Nkwene Clinic Government Rural Referral Yes 
 Ntshanini Clinic Government Rural Referral No 
 Our Lady of Sorrows Clinic Faith-based Rural Referral No 
 Phunga Clinic Government Rural Alternate No 
1 Total = 92: Hospitals (n=8); Health Centers (n=5); Clinics (n=77); Public Health Unit (n=2); Referral (n=69); Alternate (n=23); Enrollment (n=78). 
2 Self-defined by providers interviewed on facility characteristics. 
3 Referral: facility to which the client was referred for HIV care at diagnosis; Alternate: facility where either the client reported receiving HIV care or study   
personnel learned from staff or records at the referral facility where the client may have enrolled for HIV care. 
4 Facilities at which study personnel verified at least one client had enrolled in HIV care. 
5 Non-governmental organization. 
6 Name withheld for confidentiality purposes.  
 
 
